Publications

Articles In Scientific Peer-Reviewed Journals

International Journals (ΜEDLINE or PUBMED catalogue)

  1. Pepelassi E., Bissada N.F., Greenwell H., Farah C.F. Doxycycline - tricalcium phosphate composite graft facilitates osseous healing in advanced periodontal furcation defects. Journal of Periodontology 1991; 62: 106-115.
  2. Pepelassi E., Diamanti-Kipioti A. Selection of the most accurate method of conventional radiography for the assessment of periodontal osseous destruction. Journal of Clinical Periodontology 1997; 24: 557-567.
  3. Pepelassi E.A., Tsiklakis K., Diamanti-Kipioti A. Radiographic detection and assessment of the periodontal endosseous defects. Journal of Clinical Periodontology 2000; 27:224-230.
  4. Antonadou D., Pepelassi M., Synodinou M., Puglisi M., Throuvalas N. Prophylactic use of aminofostine to prevent radiochemotherapy induced mucositis and xerostomia in head – and – neck cancer. International Journal of Radiation Oncology Biology Physics 2002; 52(3): 739-747.
  5. Tsami A., Pepelassi E., Gizani S., Komboli M., Papagiannoulis L., Mantzavinos M. Oral hygiene and periodontal treatment needs in young individuals with special needs in Greece. JournalofDisabilityandOralHealth 2004; 5(1): 57-64.
  6. Pepelassi E., Tsami A., Komboli M. Root caries in periodontally treated patients in relation to their compliance with suggested periodontal maintenance intervals. CompendiumofContinuingEducationinDentistry 2005; 26: 835-845.
  7. Kavvadia K., Pepelassi E., Alexandridis C.,  Arkadopoulou A., Polyzois G., Tossios K. Gingival fibromatosis and significant tooth eruption delay in an 11 years old male: 30 months follow-up. InternationalJournalofPaediatricDentistry 2005; 15: 294-302.
  8. Pepelassi E., Vassilopoulos S., Poulios A., Sarris S. The application of laterally positioned flap for root coverage in childhood. European Journal of Paediatric Dentistry 2005; (3): Suppl.13-18.
  9. Dereka X.E., Markopoulou C.E., Mamalis A., Pepelassi E., Vrotsos I.A. Time-and dose-dependent mitogenic effect of bFGF combined with different bone graft materials. An in vitro study. Clinical Oral Implants Research 2006; 17(5): 554-559.
  10. Kossioni A., Pepelassi E., Kourtis S., Vougiouklakis G. A review of the comprehensive care clinic at the University of Athens in Greece. Eurocondenser 2006; 8(1): 12-14.
  11. Pepelassi E.A., Markopoulou C.E., Dereka X.E., Mamalis A.A., Vrotsos I.A.,  Koutsilieris M. Platelet-rich plasma effect on periodontally affected human gingival fibroblasts: an in vitro study. Journal of the International Academy of Periodontology 2009; 11: 160-168.
  12. C. E. Markopoulou, P. Markopoulos, X. E. Dereka, E. Pepelassi, I. A. Vrotsos. Effect of homologous PRP on proliferation of human periodontally affected osteoblasts. In vitro preliminary study. Report of a case. JournalofMusculoskeletalNeuronalInteractions2009; 9: 167-172.
  13. A. Tsami, E. Pepelassi, G. Kodovazenitis, M. Komboli. Parameters affecting tooth loss during periodontal maintenance in a Greek population. Journal of the American Dental Association 2009;140:1100-1107.
  14. Markou N., Pepelassi E., Vavouraki H., Stamatakis H., Nikolopoulos G., Vrotsos I., Tsiklakis K. Treatment of periodontal endosseous defects with platelet-rich plasma alone or in combination with demineralized freeze-dried bone allograft: A comparative clinical trial. Journal of Periodontology 2009; 80: 1911-1919.
  15. Kotsovilis S., Markou N., Pepelassi E., Nikolidakis D. The adjunctive use of platelet-rich plasma in the therapy of periodontal intraosseous defects: a systematic review. Journal of Periodontal Research 2010; 45: 428-443.
  16. Markou N., Pepelassi E., Kotsovilis S., Vrotsos I., Vavouraki H., Stamatakis H.C. The use of platelet-rich plasma combined with demineralized freeze-dried bone allograft in the treatment of periodontal endosseous defects: a report of two clinical cases. Journal of the American Dental Association 2010; 141(8): 967-978.
  17. Mouzakiti E., Pepelassi E., Fanourakis G., Markopoulou C., Tseleni-Balafouta S., Vrotsos I.  The effect of smoking on the mRNA expression of MMPs and TIMP-1 in untreated chronic periodontitis patients: A cross-sectional study. Journal of Periodontal Research 2011; 46 (5): 576-583.
  18. Markopoulou C.E., Dereka X.E., Vavouraki H.N., Pepelassi E.A., Mamalis A.A., I.K. Karoussis, Vrotsos I.A. Effect of rhTGF-β1 combined with bone grafts on human periodontal cell differentiation. Growth Factors 2011; 29(1): 14-20.
  19. Patsouri A., Mavrogiannea A., Pepelassi E., Gaintantzopoulou M., Kakaboura A. Clinical effectiveness of a desensitizing system on dentin hypersensitivity in periodontitis patients. American Journal of Dentistry 2011; 24(2): 85-92.
  20. Loukideli M., Tsami A., Pepelassi E., Komboli M., Doukoudakis A. Root proximity characteristics and type of alveolar bone loss: a case-control study. Journal of the International Academy of Periodontology 2011; 13(1): 73-79.
  21. Plessas A., Pepelassi E. Dental and periodontal complications of lip and tongue piercing: Prevalence and influencing factors. Australian Dental Journal  2012; 57: 71–78.
  22. Pepelassi E., Nicopoulou-Karayianni K.,  Archontopoulou A.D., Mitsea A.,  Kavadella A., Tsiklakis K., Vrotsos I., Devlin H., Horner K.. The relationship between osteoporosis and periodontitis in women aged 45–70 years. OralDiseases 2012; 18 (4): 353-359.
  23. Mouzakiti E., Pepelassi  E., Fanourakis G., Markopoulou C., Tseleni-Balafouta S.,  Vrotsos I. Expression of MMPs and TIMP-1 in smoker and nonsmoker chronic periodontitis patients before and after periodontal treatment. Journal of Periodontal Research 2012; 47(4): 532-542.
  24. Xynogala I., Pepelassi E., Perrea D., Agrogiannis G., Pantopoulou A., Patsouris E.,  Vrotsos I.  Adiponectin and interleukin-6 levels in insulin-treated diabetic rats with experimental periodontitis. Brazilian Oral Research 2012;26(1): 71–76.
  25. Pepelassi E., Xynogala I., Perrea D., Agrogiannis G., Pantopoulou A., Patsouris E., Vrotsos I. Histometric Assessment of the Effect of Diabetes Mellitus on Experimentally Induced Periodontitis in Rats. Journal of the International Academy of Periodontology 2012; 14(2): 35-41.
  26. Loukideli M., Tsami A., Pepelassi E., Vrotsos I. The effect of root proximity on the dimensions of the interdental space: a case control study. Indian Journal of Stomatology, Jan-March 2013.
  27. Zoumpopoulou G., Pepelassi E., Papaioannou W., Georgalaki M., Maragkoudakis P.A., Tarantilis P., Tsakalidou E., Papadimitriou K. Incidence of bacteriocins produced by food-related lactic acid bacteria active towards oral pathogens. International Journal of Mollecular Sciences 2013; 14(3): 4640-4654.
  28. Pepelassi E., Rahiotis C., Peponi E., Kakaboura A., Vrotsos I. Effectiveness of an in-office arginine–calcium carbonate paste on dentine hypersensitivity in periodontitis patients: a double-blind, randomized controlled trial.  Journal of  Clinical Periodontology 2015; 42(1): 37–45. doi: 10.1111/jcpe.12319.

Hellenic Journals

  1. Pepelassi E., Vrotsos I. The biologic concept and basic principles of the use of osseous grafts in the treatment of periodontal defects. Odontostomatological Progress 1991; 45(6): 327-336.
  2. Pepelassi E., Andronikaki A., Mitsis F. Removal of extrinsic tooth stains by using air powder abrasive system. Analecta Periodontologica 1991; 2:142-146.
  3. Pepelassi E.A., Vrotsos I.A. The use of grafts with osseous origin in the treatment of periodontal osseous defects. Odontostomatological Progress 1992; 46(6): 285-296.
  4. Pepelassi E.A., Vrotsos I.A. Osseous grafts in periodontal treatment. Analecta Periodontologica 1992; 3:143-151.
  5. Pepelassi E., Paraschis A. Current status of surgery in periodontal treatment. Contemporary Dentist1992; 12(4):253-261.
  6. Pepelassi E.A., Vrotsos I.A. The use of non-osseous grafts in the treatment of periodontal osseous defects. Odontostomatological Progress 1993; 47(1):53-66.
  7. Pepelassi E.A. Local delivery of tetracyclines in periodontal therapy. Analecta Periodontologica 1993; 4:26-38.
  8. Pepelassi E.A., Diamanti-Kipioti A. Complications and technical difficulties in the clinical application of guided tissue regeneration. Analecta Periodontologica 1994; 5: 118-130.
  9. Pepelassi E. Comparative evaluation of radiographic and surgical measurements in periodontal osseous destruction. Analecta Periodontologica 1995; 6:188-192.
  10. Pepelassi E.,Vrotsos I.A. Surgical and non-surgical periodontal treatment. Analecta Periodontologica 1996; 7: 125-133.
  11. Pepelassi E.A., Vrotsos I.A. Periodontal surgery and orthodontic treatment in adults. Odontostomatological Progress 1999; 53(1):26-35.
  12. Pepelassi E., Makridis S., Vrotsos I. Etiological consideration of the periodontal therapeutic approach in the maxillary anterior dental area.  Odontostomatological Progress 2000; 54(1): 19-28.
  13. Pepelassi E., Makridis S., Vrotsos I. Surgical crown lengthening. Biologic and esthetic parameters. Odontostomatological Progress 2000; 54(2): 167-176.
  14. The gingival bleeding as a symptom of periodontal disease-an index of the children’s behavior. Tsami-Pandi A., Pepelassi-Kostopoulou E., Komboli-Kontovazeniti M., Mantzavinos Z. Pedodontia 2001; 15(2): 65-72.
  15. 15.Tsami A., Pepelassi E., Komboli M., Mantzavinos Z. Frequency and distribution of the periodontal disease symptoms in an adult population group. Hellenic Stomatological Review 2001; 45: 47-55.
  16. Arkadopoulou A.F., Pepelassi E.A., Vrotsos J.A. Osteoporosis/osteopenia and periodontal disease. Odontostomatological Progress 2002; 56(3): 390-398.
  17. Koumanou M. Pelekanos S., Pepelassi E. Preparation of molars for fixed prosthodontic restoration according to their periodontal and dental condition.  Odontostomatological Progress 2002; 56(1): 120-131.
  18. Arkadopoulou A.F., Pepelassi E.A., Vrotsos I.A. Osteoporosis/osteopenia and periodontal disease. Bone 2003; 14: 223-229.
  19. Pepelassi E. Long-term evaluation of the effectiveness of guided tissue regeneration. Hellenic Stomatological Review 2003; 47: 341-349.
  20. Vrahopoulos Th.P., Pepelassi E.A. The role of cementum in periodontal wound healing and regeneration. Odontostomatological Progress 2003; 57(2): 257-269.
  21. Spyrou S., Pepelassi E., Vrahopoulos Th.P. The role of local drug delivery systems in periodontal therapy. Odontostomatological Progress 2003; 57(3): 325-339.
  22. Poulios A., Markou N., Pepelassi E., Markopoulou K. Abnormal frenulum: Influence on periodontal tissues. Prevention and treatment. Odontostomatological News. 2003; 4(1,2): 9-15.
  23. Silvestros S., Pepelassi E., Papavassiliou G. Localized ridge preservation-augmentation using guided bone regeneration. Odontostomatological Progress 2003; 57(3): 325-339.
  24. Markou N., Almagout T., Pepelassi E., Silvestros. Rehabilitation of the edentulous and reduced mandible by implant supported prostheses. Odontostomatological News 2003; 4(3): 80-87.
  25. Arkadopoulou A., Pepelassi E., Vrotsos I.A. Osteoporosis and osseointegration. Odontostomatological Progress 2004; 58(4): 168-177.
  26. Tsami A., Gizani S., Pepelassi E., Komboli M. Oral hygiene and periodontal disease: Dental knowledge, attitude and behavior of mothers towards their children in relation to their information source. Pedodontia 2004; 18(1): 7-22.
  27. Vrahopoulos T.P., Dereka X.E., Pepelassi E.A. The periodontal abscess. Hellenic Stomatological Review 2004; 48(2): 159-165.
  28. Lignos P., Pepelassi E., Vrotsos I.A. Frequency of intraoperative and postoperative complications of periodontal surgery. Odontostomatological Progress 2004; 58(3): 333-351.
  29. Giannakoura A., Pepelassi E., Vrotsos I. Tooth mobility and periodontal treatment. Odontostomatological Progress 2005; 59(3): 318-330.
  30. Pepelassi E., Tsami A. Critical factors for the therapeutic management of patients with desquamative and periodontal defects.  Hellenic Stomatological Review 2004; 48(2): 159-165.
  31. Tsami A., Pepelassi E., Kompoli M., Tsiklakis K. Is osseous defect morphology a prognostic indicator of periodontal disease progression in the anterior teeth? Evaluation by digital radiography. Odontostomatological Progress 2005; 59(1): 47-63.
  32. Tsami A., Pepelassi E., Kompoli M., Tsiklakis K. Digital radiographic evaluation of factors influencing the furcation defect progression of periodontally untreated patients. Odontostomatological Progress 2006; 60(1): 18-38.
  33. Koumanou M., Pelekanos S., Pepelassi E., Koutayas S.O. Double crown systems: Classification and clinical applications in fixed and removable prosthodontics. Odontostomatological Progress 2006; 60(1): 68-88.
  34. Tsami A., Pepelassi E., Koutsochristou V., Komboli M. Knowledge, attitude and behavior of the periodontally treated patients during the periodontal maintenance phase. Odontostomatological Progress 2006; 60(3): 306-328.
  35. Kotsovilis S., Pepelassi E., Zachariadis K., Karoussis I.K. Peri-implant plastic surgery. Odontostomatological Progress 2006; 60(3): 340-360.
  36. Maridaki K., Pepelassi E., Donta C., Karayianni K. Correlation of the dental condition to the frequency of dental visits and the oral hygiene habits. Odontostomatological Progress 2007; 61(1): 96-107.
  37. Kotsovilis S., Markou N., Pepelassi E., Fourmouzis I. The application of platelet rich plasma (PRP) in alveolar ridge preservation. A report of two clinical cases and a literature review. Odontostomatological Progress 2007; 61(2): 172-193.
  38. Archontopoulou A.D., Pepelassi E., Loizos E. Gene polymorphisms of interleukin-1 and periodontal diseases. Odontostomatological Progress 2007; 61(3): 341-359.
  39. Pepelassi Ε., Tsami Α., Coutsochristou V., Kompoli Μ., Vrotsos Ι. Evaluation οf the knowledge, attitude and behavior οf elementary schoolchildren in relation to oral health, oral hygiene and periodοntal disease. Pedodontia  2007; 21(2): 53-62.
  40. Tsami Α., Pepelassi Ε., Coutsochristou V., Kompoli Μ., Vrotsos Ι. Evaluation οf a possible relationship between parents and their elementary schoolchildren in the knowledge, attitude and behavior concerning oral health, oral hygiene and periodοntal disease. Pedodontia 2007; 21(1): 6-15.
  41. Koutsochristou V., Pepelassi Ε., Tsami Α. Mother's role in children's oral health care education. Α study in children οf kindergarten age. Pedodontia 2006; 20(1): 16-27.
  42. Tsami Α. Pepelassi Ε., Koutsochristou V., Kompoli M. Comparison of the response to periodontal maintenance between medically compromised and non-compromised patients. Hellenic Stomatological Review 2007; 51(3): 261-273.
  43. Mouzakiti E., Pepelassi E. Periodontitis and gene polymorphisms of vitamin D receptor. Odontostomatological Progress 2008; 62(1): 30-42.
  44. Tsami A., Pepelassi E.A., Kontovazenitis G., Koutsochristou V., Kompoli M. Frequency and distribution of furcation defects in chronic periodontitis patients. Hellenic Stomatological Review 2008; 52(1): 25-35.
  45. Mavrogiannea A., Patsouri A., Pepelassi E., Gaintantzopoulou M. Cervical sensitivity: Mechanism-etiology-treatment. Hellenic Stomatological Review 2008; 52: 341-351.
  46. Kotsovilis S., Markou N., Pepelassi E. Platelet-rich plasma (PRP): Historical evolution, preparation methods and biologic action. Hellenic Stomatological Review 2008; 52(4): 387-396.
  47. Markopoulou C., Dereka X., Mamalis, Pepelassi E., Vrotsos I. Study of the effect of two bone grafts on periodontal ligament cell differentiation. Odontostomatological Progress 2008; 62(3): 369-378.
  48. Kotsovilis S., Pepelassi E., Mandas D., Papazoglou E. Surgical treatment of gingival enlargement and root resection; a case report. Odontostomatological Progress 2008; 62(2): 174-190.
  49. Tsami A., Pepelassi E., Koutsochristou V., Kompoli M. Migration of the anterior teeth in adolescents: Is it correlated to the periodontal disease? Pedodontia 2008; 22(4):166-172.
  50. Vlachodimitri M.E., Pepelassi E. Postextraction alveolar ridge changes. Hellenic Stomatological Review 2009; 22(3): 223-232.
  51. Vrettos A., Pepelassi E. New biologic concept on the prevention of infective endocarditis in Dentistry. Hellenic Stomatological Review 2009; 53(1): 59-69.
  52. Gkikas G., Xynogala I., Pepelassi E. The effect of obesity on the oral cavity. Hellenic Stomatological Review 2009; 53(4): 299-308.
  53. Pepelassi E., Xynogala I. Current status of regenerative techniques. Odontostomatological Progress 2009; 63(1): 126-145.
  54. Tsami A., Pepelassi E., Koutsochristou V., Komboli M. Evaluation of the factors influencing the pathologic migration of the anterior periodontally involved teeth. Hellenic Stomatological Review 2009; 53(3): 177-185
  55. Mouzakiti E., Pepelassi E. Bisphosphonate-induced osteonecrosis of the jaws. Etiology, diagnosis, prevention and treatment. Odontostomatological Progress 2009; 63(2): 248-269.
  56. Tsami A., Pepelassi E., Kontovazenitis G., Koutsochristou V., Komboli M. Is the patient response to the maintenance treatment predictable prior to the periodontal treatment initiation? Hellenic Stomatological Review 2009; 53(2): 131-141.
  57. Tsami A., Pepelassi E., Kontovazenitis G., Koutsochristou V., Komboli M. Factors modifying the response of the periodontally treated patients to the maintenance care after enrollment. Hellenic Stomatological Review 2010; 54(4): 281-290.
  58. Trianti M., Poimeniva A., Pepelassi E., E. Papazoglou. Evidence based therapeutic management of a complex dental case. Odontostomatological Progress 2010; 64(1): 108-122.
  59. Pepelassi E., Archontopoulou A., Vrotsos I. Failure in periodontal treatment. Odontostomatological Progress 2010; 64(2): 352-370.
  60. Kotsovilis S., GlinouT.M., Pepelassi E. Clinical laser applications in the treatment of periodontitis and peri-implantitis. Analecta Periodontologica 2010; 21(1): 1-14.
  61. Tsami A., Pepelassi E., Kontovazenitis G., Koutsochristou V., Komboli M. Proximal maxillary furcation defects: Is there a possibility for radiographic imaging? Hellenic Stomatological Review 2010; 54(3): 207-214.
  62. Peponi E., Pepelassi E. The application of acellular dermal matrix in Periodontology. Hellenic Stomatological Review 2011; 55(1): 57-68.
  63. Kondylis T., Pepelassi E. The present status of photodynamic therapy in Periodontology. Hellenic Stomatological Review 2011; 55(4): 327-337.
  64. Plessas A., Pepelassi E. Piercing complications in the oral cavity. Hellenic Stomatological Review 2011; 55(4): 345-351.
  65. Lempekou A., Pepelassi E. Relatioship between rheumatoid arthritis and periodontitis. Hellenic Stomatological Review 2011; 55(2): 135-148.
  66. Papachatzopoulou A., Pepelassi E. Infrared spectroscopy, optic spectroscopy and optical coherence tomography in Periodontology. Hellenic Stomatological Review 2011; 55(2): 163-168.
  67. Peponi E., Pepelassi E. Periodontal disease and hypertension. Hellenic Stomatological Review 2012; 56(2): 65-71.
  68. Voltidi E., Kompotiati T., Pepelassi E., Markou N., Roussou I. Soft tissue preservation and management in the anterior aesthetic area in implant dentistry. Odontostomatological Progress 2012; 66(1): 88-104.
  69. Peponi E., Pepelassi E. Periodontal disease and preeclampsia. Hellenic Stomatological Review 2012; 56(3): 217-224.
  70. Kondylis T., Pepelassi E. Mesenchymal stem cell transplantation and gene transfer for periodontal tissue regeneration. Hellenic Stomatological Review 2013; 57(1): 39-71.
  71. Artopoulou I.I., Pepelassi E., Mouzakiti E., Zerva P., Tzerbos F. Multidisciplinary management of a patient presented with bisphosphonate-related osteonecrosis of the maxilla: A case report. Odontostomatological Progress 2013; 67(1): 28-36.

Books

Athanasouli Th., Nikolatou-Galiti O., Tzoutzas I., Kavadia K., Pepelassi E. The oral health and the oncology patient. Publisher Medical Editions Litsas, Athens 2007.

Book Chapters

  1. Regenerative techniques. Pepelassi E. Chapter in the Textbook “Clinical Periodontology” Mantzavinos Z., Vrotsos I. Publisher Medical Editions Litsas, Athens 2002.
  2. Therapeutic management of furcation defects. Pepelassi E. Chapter in the Textbook “Clinical Periodontology” Mantzavinos Z., Vrotsos I. Publisher Medical Editions Litsas, Athens 2002.

Articles In Volumes In Honorary

  1. Restoration of the periodontal defects in the periodontal treatment. Pepelassi E. Volume in honorary for Professor Z. Mantzavinos, Athens 2003, 491-503.
  2. The use of free gingival graft for root coverage. Literature review and case presentation. Georgiou E.N., Pepelassi E.A. Volume in honorary for Professor D. Andritsakis, Athens 2008; 155-170.

Articles In Hellenic Journals With English Text

  1. Karoussis I.K., Arkadopoulou A.F., Pepelassi E.A., Xenoudi P., Vrotsos I.A. Ridge augmentation by using connective tissue grafts. A review of the literature and case reports. Hellenic Dental Journal 2006; 16: 17-21.
  2. Pepelassi E.A., Karoussis I.K., Vrotsos I.A. Prevention and management of the complications of radiation therapy in the oral cavity. Hellenic Dental Journal 2007; 17:17-26.
  3. Dereka X.E., Markopoulou C.E., Pepelassi E., Mamalis A.A., Vrotsos I.A. Mitogenic effect of growth factors on periodontally affected human gingival fibroblasts.. Hellenic Dental Journal 2008-2009; 18-19: 13-18.

Articles In Annals of Dental Congresses

  1. Pepelassi E. The difficult periodontal treatment. Annals of the 24th Hellenic Dental Congress 2004: 435-441 (#193).

Doxycycline-tricalcium phosphate composite graft facilitates osseous healing in advanced periodontal furcation defects. Pepelassi E, Bissada NF, Greenwell H, Farah CF. JournalofPeriodontology 1991; 62(2): 106-115. (90 citations)

  1. Akbay A, Baran C, Günhan Ö, Özmeriç N, Baloş K. Periodontal regenerative potential of autogenous periodontal ligament grafts in class II furcation defects.Journal of Periodontology 2005; 76 (4): 595-604.
  2. Alkan A, & Erdem E. Histomorphometric evaluation of the effect of doxycycline on the healing of bone defects in experimental diabetes mellitus: A pilot study. Journal of Oral and Maxillofacial Surgery 2002; 60(8 SUPPL. 1): 898-904.
  3. Bichara J, Greenwell H, Drisko C, Wittwer JW, Vest TM, Yancey J, Goldsmith J, Rebitski G. The effect of postsurgical naproxen and a bioabsorbable membrane on osseous healing in intrabony defects. Journal of Periodontology 1999; 70 (8): 869-877.
  4. Brad CT, Rivera-Hidalgo F, Harrison JW, Williams FE, Guo IY. Influence of three membrane types on healing of bone defects. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodology 1996; 82 (4): 365-374.
  5. Calongne KB, Aichelmann-Reidy ME, Yukna RA, Mayer ET. Clinical comparison of microporous biocompatible composite of PMMA, PHEMA and calcium hydroxide grafts and expanded polytetrafluoroethylene barrier membranes in human mandibular molar class II furcations. A case series. Journal of Periodontology 2001; 72 (10): 1451-1459.
  6. Cattabriga M, Pedrazzoli V, Wilson Jr TG. The conservative approach in the treatment of furcation lesions.Periodontology 2000, 2000; 22 (1): 133-153.
  7. Chaturvedi R, Gill A, Sikri P. Evaluation of the regenerative potential of 25% doxycycline-loaded biodegradable membrane vs biodegradable membrane alone in the treatment of human periodontal infrabony defects: A clinical and radiological study. Indian Journal of Dental Research 2008; 19 (2): 116-123.
  8. Couri CJ, Maze GI, Hinkson DW, Collins III BH, Dawson DV. Medical grade calcium sulfate hemihydrate versus expanded polytetrafluoroethylene in the treatment of mandibular class II furcations. Journal of Periodontology 2002; 73 (11): 1352-1359.
  9. Del Peloso Ribeiro É, Bittencourt S, Ambrosano GMB, Nociti Jr FH, Sallum EA, Sallum AW, Casati MZ. Povidone-iodine used as an adjunct to non-surgical treatment of furcation involvements. Journal of Periodontology 2006; 77 (2): 211-217.
  10. Del Peloso Ribeiro É, Bittencourt S, Nociti Jr FH, Sallum EA, Sallum AW, Casati MZ. Comparative study of ultrasonic instrumentation for the non-surgical treatment of interproximal and non-interproximal furcation involvements. Journal of Periodontology 2007; 78 (2): 224-230.
  11. Froum SJ, Weinberg MA, Tarnow D. Comparison of bioactive glass synthetic bone graft particles and open debridement in the treatment of human periodontal defects. A clinical study. Journal of Periodontology 1998;69 (6): 698-709.
  12. Haney JM, Leknes KN, Wikesjö UME. Recurrence of mandibular molar furcation defects following citric acid root treatment and coronally advanced flap procedures. International Journal of Periodontics and Restorative Dentistry 1997; 17(6): 529-535.
  13. Honnorat-Benabbou VC, Lebugle AA, Sallek B, Duffaut-Lagarrigue D. Stability study of tetracyclines with respect to their use in slow release systems. Journal of Materials Science: Materials in Medicine 2001; 12 (2): 107-110.
  14. Jeong Park Y, Moo Lee Y, Nae Park S, Yoon Sheen S, Pyoung Chung C, Lee SJ. Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration.Biomaterials 2000; 21(2): 153-159.
  15. Karatzas S, Zavras A, Greenspan D, Amar S. Histologic observations of periodontal wound healing after treatment with PerioGlas in nonhuman primates. International Journal of Periodontics and Restorative Dentistry 1999; 19 (5): 489-499.
  16. Karring T, Cortellini P. Regenerative therapy: Furcation defects. Periodontology 2000 1999; 19 (1): 115-137.
  17. Kim S, Chung T, Kim MS, Lim S. The effect of high local concentrations of antibiotics on demineralized bone induction in rats. Journal of Oral and Maxillofacial Surgery 2004; 62 (6): 708-713.
  18. Kinaia BM, Steiger J, Neely AL, Shah M, Bhola M. Treatment of class II molar furcation involvement: Meta-analyses of reentry results.Journal of Periodontology2011; 82(3): 413-428.
  19. Lamb III JW, Greenwell H, Drisko C, Henderson RD, Scheetz JP, Rebitski G. A comparison of porous and non-porous teflon membrane plus demineralized freeze-dried bone allograft in the treatment of class II buccal/lingual furcation defects: A clinical reentry study. Journal of Periodontology 2001;72(11): 1580-1587.
  20. Lee J, Nam S, Im S, Park Y, Lee Y, Seol Y, Lee S. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. Journal of Controlled Release 2002; 78 (1-3): 187-197.
  21. Maragos P, Bissada NF, Wang R, Cole BP. Comparison of three methods using calcium sulfate as a Graft/Barrier material for the treatment of class II mandibular molar furcation defects. International Journal of Periodontics and Restorative Dentistry 2002; 22 (5): 493-501.
  22. Marcaccini AM, Pavanelo Â, Nogueira AVB, de Souza JAC, Porciúncula HF, Cirelli JA. Morphometric study of the root anatomy in furcation area of mandibular first molars. Journal of Applied Oral Science 2012; 20 (1): 76-81.
  23. Marinescu A, Carligeriu V, Nica L, Onisei D, Rusu D, Boariu M, Stratul S. Evaluation of treatment techniques for advanced (grade II - IV) furcation defects. A literature review of the regenerative methods. Timisoara Medical Journal 2011; 61 (1-2): 115-124.
  24. Masters LB, Mellonig JT, Brunsvold MA, Nummikoski PV. A clinical evaluation of demineralized freeze-dried bone allograft in combination with tetracycline in the treatment of periodontal osseous defects. Journal of Periodontology 1996; 67 (8): 770-781.
  25. Mehlbauer MJ, Greenwell H, Nouneh I, Drisko C, Wittwer JW, Yancey J, Rebitski G. Improved closure rate of class III furcations using a layered GTR technique. International Journal of Periodontics and Restorative Dentistry 2000; 20 (3): 285-295.
  26. Miranda DAO, Blumenthal NM, Sorensen RG, Wozney JM, Wikesjö UME. Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons. Journal of Periodontology 2005; 76 (2): 210-220.
  27. Mizuno H, Hata K, Kojima K, Bonassar, LJ, Vacanti CA, Ueda M. A novel approach to regenerating periodontal tissue by grafting autologous cultured periosteum. Tissue Engineering 2006; 12 (5): 1227-1235.
  28. Murashima Y, Yoshikawa G, Wadachi R, Sawada N, Suda H. Calcium sulphate as a bone substitute for various osseous defects in conjunction with apicectomy. International Endodontic Journal 2002; 35 (9): 768-774.
  29. Naaman NB, Ouhayoun J. Bone formation with discs or particles of natural coral skeleton plus polyglactin 910 mesh: Histologic evaluation in rat calvaria. International Journal of Oral and Maxillofacial Implants 1998; 13 (1): 115-120.
  30. Nieri M, Clauser C, Franceschi D, Pagliaro U, Saletta D, Pini-Prato G. Randomized clinical trials in implant therapy: Relationships among methodological, statistical, clinical, paratextual features and number of citations. Clinical Oral Implants Research 2007; 8 (4): 419-431.
  31. Pandit N, Gupta R, Gupta S. A comparative evaluation of biphasic calcium phosphate material and bioglass in the treatment of periodontal osseous defects: A clinical and radiological study. Journal of Contemporary Dental Practice 2010; 11(2); 25-32.
  32. Pappalardo, S., Baglio, O. A., Grassi, R. F., Grivetto, F., & Mortellaro, C. (2005). Mandibular bone deficit with a histologic study in man. Journal of Craniofacial Surgery, 16(1), 174-180.
  33. Park JB.Treatment of peri-implantitis with deproteinised bovine bone and tetracycline: A case report. Gerodontology, 2012; 29 (2): 145-149.
  34. Pettinicchio M, Sammons R, Caputi S, Piattelli A, Traini T. Bone regeneration in sinus augmentation procedures with calcium sulphate. Microstructure and microanaytical investigations. Australian Dental Journal 2012; 57 (2): 200-206.
  35. Rossa Jr C, Marcantonio Jr E, Cirelli JA, Marcantonio RA, Spolidorio LC, Fogo JC. Regeneration of class III furcation defects with basic fibroblast growth factor (b-FGF) associated with GTR. A descriptive and histometric study in dogs. Journal of Periodontology 2000; 71(5): 775-784.
  36. Santana RB, De Mattos CML, Dyke TV. Efficacy of combined regenerative treatments in human mandibular class II furcation defects.Journal of Periodontology, 2009; 80 (11), 1756-1764.
  37. Sbordone L, Bortolaia C, Perrotti V, Pasquantonio G, Petrone G. Clinical and histologic analysis of calcium sulfate in treatment of a post-extraction defect: A case report. Implant Dentistry 2005; 14 (1): 82-87.
  38. Song Z, Zhou D, Yin G, Zheng C. In vitro release of tetracycline hydrochloride from α-TCP cement. Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering 2003; 20 (4): 586-589.
  39. Suaid FF, Ribeiro FV, Rodrigues TL, Silvério KG, Carvalho MD, Nociti Jr FH, Casati MZ, Sallum EA. Autologous periodontal ligament cells in the treatment of class II furcation defects: A study in dogs. Journal of Clinical Periodontology 2011; 38 (5): 491-498.
  40. Thomas MV, Puleo DA. Calcium sulfate: Properties and clinical applications. Journal of Biomedical Materials Research - Part B Applied Biomaterials 2009; 88 (2): 597-610.
  41. Thomas MV, Puleo DA. Infection, inflammation, and bone regeneration: A paradoxical relationship.Journal of Dental Research2011; 90(9): 1052-1061.
  42. Thomas MV, Puleo DA, Al-Sabbagh M. Calcium sulfate: A review.Journal of Long-Term Effects of Medical Implants 2005; 15 (6): 599-607.
  43. Vale HFD, Del Peloso Ribeiro É, Bittencourt S, Nociti Jr FH, Sallum EA, Casati MZ. Radiographic characteristics of furcation involvements in mandibular molars as prognostic indicators of healing after nonsurgical periodontal therapy. Journal of the American Dental Association 2009; 140 (4), 434-440.
  44. Greenwell H, Miller RL, Hill M, Johnston H, Scheetz JP. Comparison of an allograft in an experimental putty carrier and a bovine-derived xenograft used in ridge preservation: A clinical and histologic study in humans. International Journal of Oral and Maxillofacial Implants 2004; 19 (4): 491-497.
  45. Vest TM, Greenwell H, Drisko C, Wittwer JW, Bichara J, Yancey J, Goldsmith J, Rebitski G. The effect of postsurgical antibiotics and a bioabsorbable membrane on regenerative healing in class II furcation defects. Journal of Periodontology 1999; 70 (8): 878-887.
  46. Walters SP, Greenwell H, Hill M, Drisko C, Pickman K, Scheetz J P. Comparison of porous and non-porous teflon membranes plus a xenograft in the treatment of vertical osseous defects: A clinical reentry study. Journal of Periodontology 2003; 74(8): 1161-1168.
  47. Ward C, Greenwell H, Wittwer JW, Drisko C. Furcation depth and interroot separation dimensions for 5 different tooth types. International Journal of Periodontics and Restorative Dentistry 1999; 19 (3): 251-257.
  48. Yukna RA, Evans GH, Aichelmann-Reidy MB, Mayer ET. Clinical comparison of bioactive glass bone replacement graft material and expanded polytetrafluoroethylene barrier membrane in treating human mandibular molar class II furcations.Journal of Periodontology 2001; 72(2): 125-133.
  49. Yukna RA, Yukna CN. Six-year clinical evaluation of HTR synthetic bone grafts in human grade II molar furcations.Journal of Periodontal Research 1997; 32 (8): 627-633.
  50. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host modulation with antiproteinase, anti-inflammatory and bone-sparing agents. A systematic review. Annals of Periodontology 2003; 8 (1): 12-37.
  51. Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL, Gunsolley JC. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review. Annals of Periodontology 2003; 8 (1): 227-265.
  52. Garrett S. Periodontal regeneration around natural teeth. Annals of Periodontology 1996; 1 (1): 621-666.
  53. Di Battista P, Bissada NF, Ricchetti PA. Comparative effectiveness of various regenerative modalities for the treatment of localized juvenile periodontitis. Journal of Periodontology 1995; 66 (8): 673-678.
  54. Garrett S, Gantes B, Zimmerman G, Egelberg J. Treatment of mandibular Class III periodontal furcation defects. Coronally positioned flaps with and without expanded polytetrafluoroethylene membranes. Journal of Periodontology 1994; 65 (6): 592-597.
  55. Page R. Periodontal therapy: Prospects for the future. Journal of Periodontology 1993; 64 (8s): 744-753.
  56. Fuentes P, Garrett S, Nilvéus R, Egelberg J. Treatment of periodontal furcation defects. Coronally positioned flap with or without citric acid root conditioning in class II defects. Journal of Clinical Periodontology 1993; 20 (6): 425-430.
  57. Callan DP, Rohrer MD. Use of bovine-derived hydroxyapatite in the treatment of edentulous ridge defects: A human clinical and histologic case report. Journal of Periodontology 1993; 64 (6): 575-582.
  58. Chaturvedi R, Gill AS, Sikri P. Evaluation of the regenerative potential of 25% doxycycline-loaded biodegradable membrane vs biodegradable membrane alone in the treatment of human periodontal infrabony defects: A clinical and radiological study. Indian Journal of Dental Research 2008; 19 (2): 116-123.
  59. Radulović M, Brković B. Klinička primena kalcijum-sulfata u regenerativnoj terapiji koštanih defekata: prikaz slučaja. Stomatološki glasnik Srbije 2003; 50 (1): 24-28.
  60. Cohen ES. Atlas of cosmetic and reconstructive periodontal surgery, 3rd Edition. People’s Medical Publishing House, China 2007. ISBN 1-55009-267-7.
  61. Drury GI, Yukna RA. Histologic evaluation of combining tetracycline and allogeneic freeze-dried bone on bone regeneration in experimental defects in baboons. Journal of Periodontology 1991; 62 (11): 652-658.
  62. Peterson LJ, Crump TB, Rivera-Hidalgo F, Harrison JW, Williams FE, Guo IY. Influence of three membrane types on healing of bone defects. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 1996; 82 (4): 365-374.
  63. Carnevale G, Pontoriero R, Hürzeler MB. Management of furcation involvement. Periodontology 2000 1995; 9 (1):69-89.
  64. Yang SM, Kim WH, Lee SJ, Kim SY, Lim YT, Lee JY, Lee YM, Young K, Chung CP, Han  SB, Choi SM, Rhyu IC. Tissue response of calcium polyphosphate in beagle dog. 2001. http://hdl.handle.net/10371/36888
  65. Jendresen MD, Allen EP, Bayne SC, Hansson Tore L,  Klooster J,  Preston JD. Report of the committee on scientific investigation of the American Academy of Restorative Dentistry. JournalofProstheticDentistry 1992; 68 (1): 137–190.
  66. Radulović M, Brković B. Clinical use of calcium sulphate in bone regeneration therapy: Case report. StomatološkiglasnikSrbije 2003; 50 (1): 24-28.
  67. Sreekumar S. Clinical evaluation of porous hydroxyapatite bone graft (Periobone G) with and without bioabsorbable collagen membrane (Periocol). In the treatment of bilateral grade II furcation defects in mandibular first molars. Dissertation. Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore 2009. http://hdl.handle.net/123456789/3261
  68. Ciancio SG, Newman MG, Shafer R. Recent advances in periodontal diagnosis and treatment – exploring new treatment alternatives. Journal of American Dental Association 1992; 123 (10): 34-43.
  69. Lynch SE. Methods for evaluation of regenerative procedures. Journal of Periodontology 1992; 63 (12, Suppl.): 1085-1092.
  70. Seymour RA, Heasman PA. Tetracyclines in the management of periodontal diseases-a review. Journal of Clinical Periodontology 1995; 22 (1): 22-35.
  71. Machtei EE, Schallhorn RG. Successful regeneration of mandibular class-II furcation defects – an evidence – based treatment approach. International Journal of Periodontics and Restorative 1995; 15 (2): 147-167.
  72. Jendresen MD, Allen EP, Bayne SC, Donovan S, Goldman S, Hume WR, Kois JC. Annual review of selected dental literature: Report of the Committee on Scientific Investigation of the American Academy of Restorative Dentistry. Journal of Prosthetic Dentistry 1998; 80 (1): 81-120.
  73. Wiggs RB, Lobprise H, Mitchell PQ. Oral and periodontal tissue – Maintenance, augmentation, rejuvenation and regeneration. Veterinary Clinics of North America-Small Animal Practice 1998; 28 (5): 1165.
  74. Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL, Gunsolley JC. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. 2003 Workshop on Contemporary Science in Clinical Periodontics. Annals of Periodontology 2003; 8 (1) 227-265.
  75. Vest TM. Regeneration of class II furcation defects using Guidor resorbable membranes with and without systemic antibiotics. Thesis, University of Louisville 1998 (page 140).
  76. Marinescu AG, Carligeriu V, Nica L, Onisei D, Rusu D, Epistatu MBD, Cioca D, Stratul SI. Evaluation of Treatment Techniques for Advanced (Grade ii – iv) Furcation Defects. A Literature Review of the Regenerative Methods. Timisoara Medical Journal 2011; 61(1-2).
  77. Radulović M, Brković B. Clinical use of calcium sulphate in bone regeneration therapy: report of 2 cases. Serbian Dental Journal 2003; 50 (1): 24-28.
  78. Beertsen W, Quirynen M, van Steenbergue D, van der Velden U. Parodontologie (eds). Bohn Stafleu van Loghum 2009,page 284. ISBN: 9789031368860.
  79. Weiss C. WCOI 6: World Congress for Oral Implantology 6: proceedings. Administration of World Congress for Oral Implantology 6 (eds). 2004, page 228.
  80. Egelberg J. Periodontics, the scientific way: synopses of human clinical studies (eds). Odonto Science, 1995, page 498.
  81. Biological Therapies in Dentistry, Mosby-Year Book, 1991, Volumes 7-11 - Page 24.
  82. Dhaliwal HS. Comparison of linear and injected impression material techniques to determine furcation volume of maxillary molars. University of Louisville 1997, pages 3, 4, 29.
  83. Tsaou P. Effects of a mineralized human cancellous bone allograft in regeneration of mandibular class II furcation defects. Thesis, University of Michigan 2005, page 114.
  84. Park YJ, Lee YM, Park SN, Sheen SY, Chung CP, Lee SJ. Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration. Biomaterials 2000; 21 (2): 153-159.
  85. Dorozhkin SV. Calcium orthophosphates in dentistry. Journal of Materials Science: Materials in Medicine 2013; 24 (6): 1335-1363.
  86. Niemiec BA, Furman R. Osseous Surgery and Guided Tissue Regeneration, in Veterinary Periodontology (eds B. A. Niemiec), John Wiley and Sons, Inc, West Sussex, 2012. UK. doi: 10.1002/9781118705018.ch18.
  87. Theuns P. Furcation Involvement and Treatment, in Veterinary Periodontology (eds B. A. Niemiec), John Wiley and Sons, Inc, West Sussex, UK 2012. doi: 10.1002/9781118705018.ch19.
  88. Agarwal A, Bhattacharya HS, Srikanth G, Singh A. Comparative evaluation of decalcified freeze dried bone allograft with and without local doxycycline in non-contained human periodontal infrabony defects. Journal of Indian Society of  Periodontology 2013;17(4): 490-494. doi: 10.4103/0972-124X.118322.
  89. Kaur K, Sikri P. Evaluation of the effect of allograft with doxycycline versus the allograft alone in the treatment of infrabony defects: A controlled clinical and radiographical study. Dental Research Journal (Isfahan) 2013;10(2): 238-246.
  90. Heasman PA, Millett DT, Chapple IL. The periodontium and orthodontics in health and disease. Oxford medical publications (eds). Oxford University Press, 1996.ISBN: 0192625608, 9780192625601, page 311.
  91.  Selection of the most accurate method of conventional radiography for the assessment of periodontal osseous destruction. Pepelassi EA, Diamanti-Kipioti A. Journal of Clinical Periodontology 1997; 24(8): 557-567. (59 citations)
  92. Alves WEGW, Ono E, Tanaka JLO, Medici Filho E, De Moraes LC, De Moraes MEL, Castilho JCDM. Influence of image filters on the reproducibility of measurements of alveolar bone loss.Journal of Applied Oral Science 2006; 14(6): 415-420.
  93. Baksi BG. Measurement accuracy and perceived quality of imaging systems for the evaluation of periodontal structures. Odontology 2008; 96 (1): 55-60.
  94. Brägger U. Radiographic parameters: Biological significance and clinical use.Periodontology 20002005;39: 73-90.
  95. Grossmann Y, Sadan A. The prosthodontic concept of crown-to-root ratio: A review of the literature.Journal of Prosthetic Dentistry2005;93(6): 559-562.
  96. Hayes ML, Johal A. The influence of malocclusion on the diagnostic value of the orthopantomogram in the maxillary labial segment.Orthodontics and Craniofacial Research 2012;15(3): 169-177.
  97. Li G, Engström P, Welander U. Measurement accuracy of marginal bone level in digital radiographs with and without color coding.Acta Odontologica Scandinavica2007;65 (5): 254-258.
  98. Mol A. Imaging methods in periodontology. Periodontology 2000 2004, 34: 34-48.
  99. Mol A, Balasundaram A. In vitro cone beam computed tomography imaging of periodontal bone.Dentomaxillofacial Radiology2008;37 (6): 319-324.
  100. Rushton VE, Horner K, Worthington HV. Screening panoramic radiography of new adult patients: Diagnostic yield when combined with bitewing radiography and identification of selection criteria.British Dental Journal 2002;192(5): 275-279.
  101. Sakakura CE, Marcantonio Jr E, Wenzel A, Scaf G. Influence of cyclosporin A on quality of bone around integrated dental implants: A radiographic study in rabbits. Clinical Oral Implants Research 2007;18 (1): 34-39.
  102. Sameshima GT, Asgarifar KO. Assessment of Root Resorption and Root Shape: Periapical vs Panoramic Films. The Angle Orthodontist 2001; 71 (3): 185–189.
  103. Scaf G, Sakakura CE, Kalil PFD, Dearo De Morais J AN, Loffredo LCM, Wenzel A. Comparison of simulated periodontal bone defect depth measured in digital radiographs in dedicated and non-dedicated software systems. Dentomaxillofacial Radiology2006;35 (6): 422-425.
  104. Suda R, Cao C, Suzuki M, Hasegawa K, Sasa R. Attachment loss in rural chinese children over a 3-year period.Community Dentistry and Oral Epidemiology 1999; 27 (3): 216.
  105. Tervonen T, Karjalainen K, Knuuttila M, Huumonen S. Alveolar bone loss in type 1 diabetic subjects. Journal of Clinical Periodontology 2000;27 (8): 567-571.
  106. Tsugawa AJ, Verstraete FJM, Kass PH, Görrel C. Diagnostic value of the use of lateral and occlusal radiographic views in comparison with periodontal probing for the assessment of periodontal attachment of the canine teeth in dogs. American Journal of Veterinary Research 2003;64 (3): 255-261.
  107. Tugnait A, Clerehugh DV, Hirschmann PN. Survey of radiographic practices for periodontal disease in UK and Irish dental teaching hospitals. Dentomaxillofacial Radiology 2000; 29 (6): 376 – 381.
  108. Tugnait A, Clerehugh V, Hirschmann PN. The usefulness of radiographs in diagnosis and management of periodontal diseases: A review.Journal of Dentistry2000;28 (4): 219-226.
  109. Tugnait A, Clerehugh V, Hirschmann PN. Use of the b asic periodontal examination and radiographs in the assessment of periodontal diseases in general dental practice.Journal of Dentistry 2004; 32 (1): 17-25.
  110. Tugnait A, Hirschmann PN, Clerehugh V. Validation of a model to evaluate the role of radiographs in the diagnosis and treatment planning of periodontal diseases.Journal of Dentistry2006; 34 (7): 509-515.
  111. Volchansky A, Cleaton-Jones P, Drummond S, Bönecker M. (). Technique for linear measurement on panoramic and periapical radiographs: A pilot study. Quintessence International 2006; 37 (3): 191-197.
  112. Ziebolz D, Szabadi I, Rinke S, Hornecker E, Mausberg RF. Initial periodontal screening and radiographic findings - A comparison of two methods to evaluate the periodontal situation.BMC Oral Health 2011; 11 (1): 3. doi: 10.1186/1472-6831-11-13.
  113. Du Bois AH, Kardachi B, Bartold PM. Is there a role for the use of volumetric cone beam computed tomography in periodontics? Australian Dental Journal 2012; 57: 103-108.
  114. Jendresen MD, Allen EP, Bayne SC, Donovan TE, Hansson TL, Klooster J. Annual review of selected dental literature: Report of the Committee on Scientific Investigation of the American Academy of Restorative Dentistry. Journal of Prosthetic Dentistry 1993; 70 (1): 44-85.
  115. Corbet EF, Ho DKL, Lai SML. Radiographs in periodontal disease diagnosis and management. Australian Dental Journal 2009; 54(Supplement s1): S27–S43.
  116. Fukuda CT, Carneiro SRS, Alves VTE, Pustiglioni FE, De Micheli G. Radiographic alveolar bone loss in patients undergoing periodontal maintenance. The Bulletin of Tokyo Dental College 2008; 49 (3): 99-106. http://dx.doi.org/10.2209/ tdcpublication.49.9928.
  117. Vandenberghe B, Jacobs R. The influence of tube potential on periodontal bone level measurements and subjective image quality using a digital photostimulable storage phosphor sensor. Journal of Oral and Maxillofacial Research 2010; 1 (1): e5 doi:10.5037/jomr.2010.1105 29.
  118. Gheddaf-Dam H, Najm SA, Lysitsa S, Bischof M, Nesir R. X-ray evaluation at 5–6 years of Straumann implants (part 2). Médecine Buccale Chirurgie Buccale 2010; 16 (2): 85-94. DOI: http://dx.doi.org/10.1051/mbcb/2010015.
  119. Gheddaf-Dam H, Najm SA, Lysitsa S, Bischof M, Nesir R. X-ray evaluation at 5-6 years of Straumann implants (part 1). Médecine Buccale Chirurgie Buccale 2010; 16 (1): 23-42. DOI: http://dx.doi.org/10.1051/mbcb/2009039.
  120. Fleiner J, Hannig C, Schulze D, Stricker A, Reinhilde J. Digital method for quantification of circumferential periodontal bone level using cone beam CT. Clinical Oral Investigations 2013; 17(2): 389-396. doi:10.1007/s00784-012-0715-3
  121. Talebi A, Ghambariha M, Baghaei F. Expression of P53 and Ki-67 Proteins in an Odontogenic Keratocyst. Journal of Isfahan Dental School 2006;1 (2): 1383.
  122. Deepa C. Interproximal bone loss assessment comparison of conventional and digital radiographs. Dissertation 2009. 119.82.96.198http://hdl.handle.net/123456789/3338
  123. Jablonski M. Eine Nachuntersuchung von parodontal behandelten recallpatienten in einer privatzahnärztlichen Praxis. A follow-up of treated periodontal recall patients in a private dental practice. Dissertationen der Georg-August-Universität Göttingen. 2011.http://hdl.handle.net/11858/00-1735-0000-0006-B1EC-E
  124. Knezović-Zlatarić D, Čelebić A, Brujić S. Gubitak alveolarne kosti na zubima nosačima i nenosačima u nositelja djelomičnih proteza. Šestomjesečno istraživanje. Acta stomatologica Croatica. Lipanj 2003; 37(2).
  125. Semenoff L, Tereza Aparecida Delle Semenoff TA, Fabio Luiz Miranda Pedro FLM, Evi Volpato ER, de Andrade Moreira Machado MA, Borges AH, Semenoff-Segundo A. Are Panoramic Radiographs Reliable to Diagnose Mild Alveolar Bone Resorption? ISRN Dentistry 2011, Article ID 363578, 4 pages, doi:10.5402/2011/363578/ ISRN. Published online 2011 May 4.
  126. Kerbauywd WD, de Moraeslsm LC, de Lima FR, Medici Filho E. Avaliação da perda óssea alveolar em pacientes encaminhados a especialistaem periodontia: estudo radiográfico. Rev. Odontol. UNESP, São Paulo, 2000; 29 (1/2) : 55-70. 
  127. Ivanauskaite D, Lindh C, Rohlin M. Observer performance based on marginal bone tissue visibility in Scanora Ò panoramic radiography and posterior bitewing radiography. Stomatologija Baltic Dental and Maxillofacial Journal 2008; 10: 36-43.
  128. Hoelscher BC. Passive eruption patterns in first molars. Thesis.University ofIowa 2011.http://ir.uiowa.edu/etd
  129. White SC, Heslop EW, Hollender LG, Mosier KM, Ruprecht A, Shrout MK. Parameters of radiologic care: an official report of the American Academy of Oral and Maxillofacial Radiology. Oral Surg Oral Med 2001; 91(5): 498-511.
  130. Walker SL, Tieu LD, Flores-Mir C. Radiographic comparison of the extent of orthodontically induced external apical root resorption in vital and root-filled teeth: a systematic review. European Journal of Orthodontics 2013; 35(6): 796. doi: 10.1093/ejo/cjs101
  131. White S, Pharoah MJ.  Oral Radiology: Principles and Interpretation (eds). 6th ed. Mosby Elsevier 2009.
  132. Balasundaram A. Cone beam computed tomography imaging of periodontal bone. Dissertation. The University of North Carolina at Chapel Hill, 2008.
  133. International Association of Maxillofacial Radiology. Dento maxillo facial radiology. Vol. 32. Japan Science Press, 2003.
  134. de Mendonça MP. Análise Radiográfica Interproximal de Perda Óssea Alveolar em Crianças e Adolescentes. Dissertation. Universidade do Grande Rio, 2007.
  135.  محمد شاه ابویی, احسان حکمتیان, مهدی ادیب راد,ایوب بهادر قبادی , Abouei MS, Hekmatian E, Adibrad a, Bahador Ghobadi A. Accuracy of vertical bitewing and bisect periapical radiography techniques in anterior mandibular teeth interdental bone resorption. Journal of Isfahan Dental School 2010; 5: 3.
  136. Znanstveni I. Gubitak alveolarne kosti na zubima nosaËima i nenosaËima u nositelja djelomiËnih proteza.© estomjeseËno istraæivanje. Acta Stomatologica  Croatica 2003; 179: 184.
  137. White S, Pharoah MJ. Radiologia Oral:Fundamentos e Interpretacao (eds). 5th ed. Mosby Elsevier 2011, Ch 17, page 557.
  138. Asgarifar KO. The comparison of the diagnostic value of panoramic radiographs to periapical radiographs in the detection of root resorption (eds). University of Southern California, 1998, pages 37, 45, 80, 95.
  139. Wilkins EM. Clinical practice of the dental hygienist Lippincott Williams & Wilkins, 1999, page 169. ISBN: 0683303627, 9780683303629.
  140. Rushton VE, Horner K, Worthington HV. Screening panoramic radiography of new adult patients: diagnostic yield when combined with bitewing radiography and identification of selection criteria. British Dental Journal 2002; 192: 275-279.
  141. Lopez R. Periodontitis in adolescents. Studies among Chilean high school students.PhD thesis. University of Aarhus; 2003:1-123.
  142. Bahrami G, Isidor F, Kirkevang LL, Vaeth M, Wenzel A. Marginal bone level in an adult Danish population. Oral Health and Preventive Dentistry 2006; 4 (2):119-127.
  143. Gómez-Polo M, Bartens F, Sala L, Tamini F, Celemín A, del Rio J. Correlation between crown-implant ratios and marginal bone resorption:  A Preliminary Clinical Study. International Journal of Prosthodontics 2010; 23(1): 33-37.
  144. De Bruyn H, Vandeweghe S, Ruyffelaert C, Cosyn J, Sennerby L. Radiographic evaluation of modern oral implants with emphasis on crestal bone level and relevance to periimplant health. Periodontology 2000. 2013; 62(1): 256-270.
  145.  Nackaerts O. Imaging in Periodontology: 2D versus 3D Visualization Techniques (eds). Informatics in Oral Medicine. 2010. DOI: 10.4018/978-1-60566-733-1.ch013
  146. Jendresen MD,  Allen EP, Bayne SC, Donovan TE, Goldman S, Hume WR, Kois JC.Annual review of selected dental literature: Report of the Committee on Scientific Investigation of the American Academy of Restorative Dentistry, The Journal of Prosthetic Dentistry 1998;80(1):81.
  147. Vandenberghe B, Sarment D. Periodontal Disease Diagnosis Using Cone Beam Computed Tomography, in Cone Beam Computed Tomography: Oral and Maxillofacial diagnosis and applications (ed A. Sarment), John Wiley and Sons, Inc, 2014, ch 11: 249-269.
  148. Deepa C, Ramesh AV, Dwarakanath CD, GayathriG. Interproximal bone loss assessment: Comparison of conventional and digital radiographs. International Journal of Contemporary Dentistry 2012; 3(3): 23-27.
  149. Hayes ML, Johal A.The influence of malocclusion on the diagnostic value of the orthopantomogram in the maxillary labial segment. Orthodontics and Craniofacial Research 2012;15(3): 169-177.
  150. De Bruyn H, Vandeweghe S, Ruyffelaert C, Cosyn J, Sennerby L. Radiographic evaluation of modern oral implants with emphasis on crestal bone level and relevance to peri-implant health. Periodontology 2000 2013;62(1):256-270.
  151. Radiographic detection and assessment of the periodontal endosseous defects. Pepelassi EA, Tsiklakis K, Diamanti-Kipioti A. Journal of Clinical Periodontology 2000; 27(4): 224-230.  (39 citations)
  152. Baljoon M, Natto S, Bergström J. Long-term effect of smoking on vertical periodontal bone loss. Journal of Clinical Periodontology 2005; 32(7): 789-797.
  153. Esmaeli F, Shirmohammadi A, Faramarzie M, Abolfazli N, Rasouli H, Fallahi S. Determination of vertical interproximal bone loss topography: Correlation between indirect digital radiographic measurement and clinical measurement.Iranian Journal of Radiology 2012; 9(2): 80-84.
  154. Grossmann Y, Sadan A. The prosthodontic concept of crown-to-root ratio: A review of the literature.Journal of Prosthetic Dentistry 2005; 93(6): 559-562.
  155. Jenkins WMM, Brocklebank LM, Winning SM, Wylupek M, Donaldson A, Strang RM. A comparison of two radiographic assessment protocols for patients with periodontal disease.British Dental Journal 2005; 198 (9): 565-569.
  156. Karhunen V, Forss H, Goebeler S, Huhtala H, Ilveskoski E, Kajander O, Karhunen PJ. Radiographic assessment of dental health in middle-aged men following sudden cardiac death.Journal of Dental Research 2006; 85 (1): 89-93.
  157. Kasaj A, Vasiliu C, Willershausen B. Assessment of alveolar bone loss and angular bony defects on panoramic radiographs.European Journal of Medical Research 2008;13 (1): 26-30.
  158. Molloy J, Wolff LF, Lopez-Guzman A, Hodges JS. (). The association of periodontal disease parameters with systemic medical conditions and tobacco use.Journal of Clinical Periodontology 2004,31 (8): 625-632.
  159. Park S, Sorensen WP, Wang H. Management and prevention of retrograde peri-implant infection from retained root tips: Two case reports. International Journal of Periodontics and Restorative Dentistry 2004;24 (5): 422-433.
  160. Rokadiya S, Malden NJ. An implant periapical lesion leading to acute osteomyelitis with isolation of staphylococcus aureus.British Dental Journal 2008;205 (9): 489-491.
  161. Rushton MN, Rushton VE. A study to determine the added value of 740 screening panoramic radiographs compared to intraoral radiography in the management of adult (>18 years) dentate patients in a primary care setting.Journal of Dentistry 2012;40 (8): 661-669.
  162. Schara R, Serša I, Skalerič U. T1 relaxation time and magnetic resonance imaging of inflamed gingival tissue. Dentomaxillofacial Radiology 2009;38 (4): 216-223.
  163. Volchansky A, Cleaton-Jones P, Drummond S, Bönecker M. (). Technique for linear measurement on panoramic and periapical radiographs: A pilot study.Quintessence International 2006;37 (3): 191-197.
  164. Ziebolz D, Stühmer C, Hornecker E, Zapf A, Mausberg RF, Chenot JF. Oral health in adult patients with congenital coagulation disorders - a case control study. Haemophilia 2011; 17 (3): 527-531.
  165. Ziebolz D, Szabadi I, Rinke S, Hornecker E, Mausberg RF. Initial periodontal screening and radiographic findings - A comparison of two methods to evaluate the periodontal situation.BMC Oral Health 2011; 11 (1): 3-6.
  166. Du Bois AH, Kardachi B, Bartold PM. Is there a role for the use of volumetric cone beam computed tomography in periodontics? Australian Dental Journal 2012; 57: 103-108.
  167. Gheddaf-Dam H, Abi Najm S, Lysitsa S, Bischof M, Nedir R. X-ray evaluation at 5–6 years of Straumann implants (part 2). Médecine Buccale Chirurgie Buccale 2010; 16 (2): 85.
  168. Corbet EF, Ho DKL, Lai SML. Radiographs in periodontal disease diagnosis and management. Australian Dental Journal 2009; 54 (Supplement s1): S27–S43.
  169. Mellanen L. The influence of HIV infection to the periodontium; a clinical, microbiological, and enzymological study. Doctoral dissertation, University of Helsinki, Helsinki 2006 http://urn.fi/URN:ISBN:952-10-3068-0
  170. Greenblatt CL Jr, Berrymen R, Brooks SL, Burton B ...Radiation-Emitting Products. The Selection of Patients for Dental Radiographic Examinations. American Dental Association, Food and Drug Administration 2012. Available at: www.ada.org
  171. Jablonski M. Eine Nachuntersuchung von parodontal behandelten Recallpatienten in einer privatzahnärztlichen Praxis. A follow-up of treated periodontal recall patients in a private dental practice. Dissertation, Georg-August-Universität Göttingen, 2011. http://hdl.handle.net/11858/00-1735-0000-0006-B1EC-E
  172. Castaño NE, García MP, Trapero CJ, Martínez BA. Autologous bone regeneration of an circumferential three walls defect.SciELO Espana, Avances en Periodoncia 2008; 20 (2). http://dx.doi.org/10.4321/S1699-65852008000200003
  173. García B, Martorell L, Martí E. Peñarrocha M. Cirugía periapical en dientes posteriores maxilares: Revisión de la bibliografía. Periapical surgery of maxillary posterior teeth. A review of the literature. SciELOEspana, MedicinaOral, PatologíaOralyCirugíaBucal (Internet) - 2006; 11(2).  ISSN 1698-6946.
  174. Knezović-Zlatarić D, Čelebić A, Brujić S. Gubitak alveolarne kosti na zubima nosačima i nenosačima u nositelja djelomičnih proteza. Šestomjesečno istraživanje.  ActaStomatologicaCroatica, 200; 37, (2) Lipanj 2003. - hrcak.srce.hr
  175. Department of Periodontology, University of Toronto. Diagnosis and Examination - Periodontal Literature Review. A project awarded by the American Academy of Periodontology.  http://www.periolitreview.com/diagexam.html
  176. Kasaj A, Vasiliu Ch, Willershausen B.Assessment of alveolar bone loss and angular bony defects on panoramic radiographs. European Journal of Medical Research 2008; 13: 26-30.
  177. Ivanauskaite D, Lindh Ch, Rangne K, Rohlin M. Comparison between Scanora® Panoramic Radiography and Bitewing Radiography in the Assessment of Marginal Bone Tissue. Stomatologija, Baltic Dental and Maxillofacial Journal 2006; 8: 9-15.
  178. Li-Ching C, Chi-Sen HSU. Implant periapical lesion－literature review International Journal of periodontics and Restorative Dentistry 2004; 24: 422-433.
  179. Li-Ching C, Chi-Sen HSU. Implant periapical lesion－literature review. Journal of Dental Science 2007; 2 (4): 179-192.
  180. Karhunen V, Forss H, Goebeler S, Huhtala H, Ilveskoski E, Kajander O, Mikkelsson J, Penttilä A, Perola M, Ranta H, Meurman JH, Karhunen PJ. Radiographic Assessment of Dental Health in Middle-aged Men Following Sudden Cardiac Death Journal of Dental Research 2006; 85 (1): 89-93.
  181. Znanstveni I. Gubitak alveolarne kosti na zubima nosaËima i nenosaËima u nositelja djelomiËnih proteza.© estomjeseËno istraæivanje. Acta Stomatologica Croatica 2003; 179: 184.
  182. de Baat C, Brands WC, Carels CEL, Jacobs R, Koole R. Het Tandheelkunig jaar (eds). Bohn Stafleu van Longhum, Houten 2006, page 35.
  183. Danan M, Fontanel F, Brion M. Parodontites severes et orthodontie (eds). Wolters Kluer France2004, page 133, 146.
  184. Axelson P, Axelson P (DDS). Diagnosis and risk prediction of periodontal diseases (eds). Quintessence Pub. Co., 2002, page 435.
  185. Baljoon M, Natto S, Abanmy A, Bergström J. Smoking and Vertical Bone Defects in a Saudi Arabian Population. Oral Health and Preventive Dentistry 2005; 3(3): 173-182.  
  186. Zamani Naser A, Zyhajehzadeh I, Khayam E. Accuracy of periapical radiography for detection of alveolar osseous defect in relation to their anatomic location. Journal of Isfahan Dental School 2006; 2(1): 35-38.
  187. Mesa F, Souki N, Galindo-Moreno P, Velasco-Torres M, O'Valle F, Bravo M. Tobacco consumption induces alveolar crest height loss independently of mandibular bone mass and bone density. Clinical Oral Implants Research 2014; 25(3): 1–7 doi: 10.1111/clr.12207
  188. Office of the Surgeon General (US); Office on Smoking and Health (US). The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2004. 6, Other Effects. http://www.ncbi.nlm.nih.gov/books/NBK44699/
  189. Faghihi Sh, Shahii Sh, Vasegh S. The Reliability and Comparison of Linear Measurements of Intraosseous Periodontal Lesions by Conventional Periapical and Digitized Radiographs. The Journal of Dentistry 2004; 5(1,2).
  190. Baljoon M, Natto S, Bergström J. Long-term effect of smoking on vertical periodontal bone loss. Journal of Clinical Periodontology 2005; 32(7):789-797.
  191. 4. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Antonadou D, Pepelassi M, Synodinou M, Puglisi M, Throuvalas N. InternationalJournalofRadiationOncologyBiologyPhysics2002; 52(3): 739-747.  (180 citations)
  192. Abitbol A, Abdel-Wahab M, Harvey M, Lewin A, Troner M, Hamilton-Nelson K, Wu J, Markoe A. Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol. American Journal of Clinical Oncology: Cancer Clinical Trials 2005; 28 (5): 449-455.
  193. Alterio D, Jereczek-Fossa BA, Fiore MR, Piperno G, Ansarin M, Orecchia R. Cancer treatment-induced oral mucositis. Anticancer Research 2007; 27 (2): 1105-1125.
  194. Andreassen CN, Grau C, Lindegaard JC. Chemical radioprotection: A critical review of amifostine as a cytoprotector in radiotherapy. Seminars in Radiation Oncology 2003; 13 (1): 62-72.
  195. Belzile M, St-Amant M, Mathieu D, Doueik A, Fortier P, Dorion D. Radiation-induced xerostomia: Is octreotide the solution? Journal of Otolaryngology - Head and Neck Surgery 2009; 38 (5): 545-551.
  196. Berk LB, Shivnani AT, Small Jr W. Pathophysiology and management of radiation-induced xerostomia. Journal of Supportive Oncology 2005; 3 (3): 191-200.
  197. Bhattacharyya GS, Biswas J, Govindbabu K, Ranade AA. Uncommon versus taken for granted: Both needs to be addressed. Indian Journal of Cancer 2011, 48 (3): 279-280.
  198. Blanc, AI, Chao KSC, El Naqa I, Franklin GE, Zakarian K, Vicic M, Deasy JO. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. International Journal of Radiation Oncology Biology Physics 2005; 62 (4): 1055-1069.
  199. Boccia R, Anné PR, Bourhis J, Brizel D, Daly C, Holloway III N, Wasserman T. Assessment and management of cutaneous reactions with amifostine administration: Findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). International Journal of Radiation Oncology Biology Physics 2004; 60 (1): 302-309.
  200. Bordón E, Henríquez-Hernández LA, Lara PC, Ruíz A, Pinar B, Rodríguez-Gallego C, Lloret M. Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs). Radiation Oncology 2010; 5 (1): 85.
  201. Borges L, Rex KL, Chen JN, Wei P, Kaufman S, Scully S, Farrell CL. A protective role for keratinocyte growth factor in a murine model of chemotherapy and radiotherapy-induced mucositis. International Journal of Radiation Oncology Biology Physics 2006; 66 (1): 254-262.
  202. Bourhis J, Blanchard P, Maillard E, Brizel DM, Movsas B, Buentzel J, Pignon JP. Effect of amifostine on survival among patients treated with radiotherapy: A meta-analysis of individual patient data. Journal of Clinical Oncology 2011; 29 (18): 2590-2597.
  203. Bourhis J, Thephamongkhol K, Pignon JP. Randomized trials of amifostine and radiotherapy: Effect on survival? Seminars in Oncology 2004; 31(SUPPL. 18): 62-66.
  204. Braaksma M, Levendag P. Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: Subcutaneous amifostine and computed tomography-based target delineation. Seminars in Oncology 2002; 29 (6 SUPPL. 19): 63-70.
  205. Braaksma M, Van Agthoven M, Nijdam W, Uyl-De Groot C, Levendag P. Costs of treatment intensification for head and neck cancer: Concomitant chemoradiation randomised for radioprotection with amifostine. European Journal of Cancer 2005; 41 (14): 2102-2111.
  206. Brizel DM. Pharmacologic approaches to radiation protection. Journal of Clinical Oncology 2007; 25 (26): 4084-4089.
  207. Brizel DM, Overgaard J. Does amifostine have a role in chemoradiation treatment? Lancet Oncology 2003; 4 (6): 378-381.
  208. Buentzel J, Micke O, Adamietz IA, Monnier A, Glatzel M, De Vries A. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: A randomized placebo-controlled phase III study. International Journal of Radiation Oncology Biology Physics 2006; 64 (3): 684-691.
  209. Büntzel J, Glatzel M, Mücke R, Bruns F, Kisters K, Micke O. Scavenging of free radicals and the late toxicity of radiochemotherapy in head and neck cancer patients.Trace Elements and Electrolytes 2006; 23 (3): 181-185.
  210. Carmona A, Corona JA, Ayala F, Velasco J, Escobar P, De Las Heras González M.. Toxicities and palliative treatment of chemoradiation applied to head and neck tumors. [Toxicidades y tratamiento de soporte de la radioquimioterapia aplicados a los tumores de cabeza y cuello] Revisiones En Cancer 2007; 21 (1): 31-38.
  211. Chao KSC, Ozyigit G, Thorsdad WL. (). Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine. Seminars in Oncology 2003; 30 (6 SUPPL. 18): 101-108.
  212. Chua DTT, Tian Y, Wei WI. Late oral complications following radiotherapy for head and neck cancers. Expert Review of Anticancer Therapy 2007; 7 (9): 1215-1224.
  213. Day TA, Chi A, Neville B, Hebert JR. Prevention of head and neck cancer. Current Oncology Reports 2007; (2): 145-153.
  214. De Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, Lee NY. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The memorial sloan-kettering cancer center experience. International Journal of Radiation Oncology Biology Physics 2006; 64 (2): 363-373.
  215. De Oliveira Lopes C, Mas JRI, Zângaro RA. Low level laser therapy in the prevention of radiotherapy-induced xerostomia and oral mucositis. [Prevenção da xerostomia e da mucosite oral induzidas por radioterapia com uso do laser de baixa potência] Radiologia Brasileira2006; 39 (2): 131-136.
  216. DemIröz C, Özkan L, CebellI G, Karada, O, ÖzşahIn EM. The effect of amifostine on acute and late radiation side effects in head and neck cancer patients. [Baş ve Boyun Kanseri Hastalari{dotless}nda Radyasyonun Akut ve Geç Yan Etkileri Üzerine Amifostinin Etkisi] Turkiye Klinikleri Journal of Medical Sciences 2012; 32 (5): 1207-1216.
  217. Dest VM. Radioprotectants: Adding quality of life to survivorship? Seminars in Oncology Nursing 2006; 22 (4): 249-256.
  218. Dörr W, Herrmann T. Efficacy of wobe-mugos® E for reduction of oral mucositis after radiotherapy: Results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study.Strahlentherapie Und Onkologie 2007; 183 (3): 121-127.
  219. Dörr W, Schlichting S, Bray MA, Flockhart IR, Hopewell JW. Effects of dexpanthenol with or without aloe vera extract on radiation-induced oral mucositis: Preclinical studies. International Journal of Radiation Biology 2005; 81 (3): 243-250.
  220. Eisbruch A. Amifostine in the treatment of head and neck cancer: Intravenous administration, subcutaneous administration, or none of the above. Journal of Clinical Oncology 2011; 29 (2): 119-121.
  221. Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, Balm AJM. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? International Journal of Radiation Oncology Biology Physics 2004; 60 (5): 1425-1439.
  222. Epstein JB, Barasch A. Taste disorders in cancer patients: Pathogenesis, and approach to assessment and management. Oral Oncology 2010; 46 (2): 77-81.
  223. Epstein JB, Thariat J, Bensadoun R, Barasch A, Murphy BA, Kolnick L, Maghami E. Oral complications of cancer and cancer therapy: From cancer treatment to survivorship. CA Cancer Journal for Clinicians 2012; 62 (6): 400-422.
  224. Fan KY, Gogineni H, Zaboli D, Lake S, Zahurak ML, Best SR, Ha PK. Comparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma. Annals of Surgical Oncology 2012; 19 (6): 1980-1987.
  225. Feio M, Sapeta P. Xerostomia in palliative care. [Xerostomia em cuidados paliativos] Acta Medica Portuguesa 2005; 18 (6): 459-466.
  226. Fleischer G, Dörr W. Amelioration of early radiation effects in oral mucosa (mouse) by intravenous or subcutaneous administration of amifostine. Strahlentherapie Und Onkologie2006; 182 (10): 567-575.
  227. Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T. The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Seminars in Oncology 2003; 30 (6 SUPPL. 18): 76-83.
  228. Gabriel DA, Shea TC, Serody JS, Moore DT, Kirby SL, Harvey D, Krasnov C. Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies. Biology of Blood and Marrow Transplantation 2005; 11 (12): 1022-1030.
  229. Garden AS, Lewin JS, Chambers MS. How to reduce radiation-related toxicity in patients with cancer of the head and neck. Current Oncology Reports 2006; 8 (2): 140-145.
  230. Georgiou M, Patapatiou G, Domoxoudis S, Pistevou-Gompaki K. Oral mucositis: Understanding the pathology and management. Hippokratia 2012; 16 (3): 215-216.
  231. Goldblum D, Ghadjar P, Curschmann J, Greiner R, Aebersold D. Prevention of radiochemotherapy-induced toxicity with amifostine in patients with malignant orbital tumors involving the lacrimal gland: A pilot study. Radiation Oncology 2008; 3 (1): 22.
  232. Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH,. Schuchter LM. American society of clinical oncology 2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants. Journal of Clinical Oncology2009; 27 (1): 127-145.
  233. Hogle WP. Cytoprotective agents used in the treatment of patients with cancer. Seminars in Oncology Nursing 2007; 23 (3): 213-224.
  234. Huber MA, Terezhalmy GT. The head and neck radiation oncology patient. Quintessence International 2003; 34 (9): 693-717.
  235. Jazieh AR, Younas A, Safa M, Redmond K, Buncher R, Howington J. Phase I clinical trial of concurrent paclitaxel, carboplatin, and external beam chest irradiation with glutamine in patients with locally advanced non-small cell lung cancer. Cancer Investigation 2007; 25 (5): 294-298.
  236. Jen Y, Shih R, Lin Y, Su W, Ku C, Chang C, Lin C. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: A dosimetric and clinical comparison with conventional radiotherapy. Radiotherapy and Oncology 2005; 75 (2): 204-209.
  237. Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, Brennan MT. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: Management strategies and economic impact. Supportive Care in Cancer 2010; 18 (8): 1061-1079.
  238. Jha N, Seikaly H, Harris J, Williams D, Liu R, McGaw T, Barnaby P. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiotherapy and Oncology 2003; 66 (3): 283-289.
  239. Klein MK. Multimodality therapy for head and neck cancer. Veterinary Clinics of North America - Small Animal Practice 2003; 33 (3): 615-628.
  240. Konings AWT, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. International Journal of Radiation Oncology Biology Physics 2005; 62 (4): 1187-1194.
  241. Konings AWT, Faber H, Vissink A, Coppes RP. Radioprotective effect of amifostine on parotid gland functioning is region dependent. International Journal of Radiation Oncology Biology Physics 2005; 63 (5): 1584-1591.
  242. Koukourakis MI. Amifostine: Is there evidence of tumor protection? Seminars in Oncology 2003; 30 (6 SUPPL. 18): 18-30.
  243. Koukourakis MI, Abatzoglou I, Sivridis L, Tsarkatsi M, Delidou H. Individualization of the subcutaneous amifostine dose during hypofractionated/accelerated radiotherapy. Anticancer Research 2006; 26 (3B): 2437-2443.
  244. Koukourakis MI, Danielidis V. Preventing radiation induced xerostomia. Cancer Treatment Reviews 2005; 31(7): 546-554.
  245. Koukourakis MI, Maltezos E. Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases. Anti-Cancer Drugs 2006; 17 (2): 133-138.
  246. Koukourakis MI, Simopoulos C, Minopoulos G, Patlakas G, Polychronidis A, Limberis V, and Manolas C. Amifostine before chemotherapy: Improved tolerance profile of the subcutaneous over the intravenous route. Clinical Cancer Research 2003; 9 (9): 3288-3293.
  247. Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine: The first selective-target and broad-spectrum radioprotector. Oncologist 2007; 12 (6): 738-747.
  248. Law A, Kennedy T, Pellitteri P, Wood C, Christie D, Yumen O. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology Biology Physics 2007; 69 (5): 1361-1368.
  249. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? Journal of the National Cancer Institute 2008; 100 (11): 773-783.
  250. Lee D. Definitive radiotherapy for squamous carcinoma of the larynx. Otolaryngologic Clinics of North America 2002; 35 (5): 1013-1033.
  251. Liu X, Guo Z, Su Y, Hong M, Cui N, Zeng Z. Long-term effect of submandibular salivary gland transfer on radiation-induced xerostomia in patients with nasopharyngeal carcinoma. Chinese Journal of Clinical Oncology 2009; 36 (24): 1384-1387.
  252. Liu X, Zeng Z, Hong M, Zhang A, Cui N, Chen F. Clinical analysis of xerostomia in patients with nasopharyngeal carcinoma after radiation therapy. Chinese-German Journal of Clinical Oncology 2005; 4 (3): 137-140.
  253. Liu X, Guo Z, Su Y, Mai H, Hong M, Cui N, Zeng Z. Oncological safty evaluation of submandibular salivary gland transfer prevents radiation-induced xerostomia in the patients with nasopharyngeal carcinoma. Chinese Journal of Cancer Prevention and Treatment 2009; 16 (22): 1804-1807.
  254. Liu X, Su Y, Jha N, Hong M, Mai H, Fan W, Guo Z. Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-year outcomes. Head and Neck 2011; 33 (3): 389-395.
  255. Lu T, Sun W, Zhao W, Chen T. Preparation of amifostine polylactide-co-glycolide microspheres and its irradiation protective to mouse through oral administration. Drug Development and Industrial Pharmacy 2011; 37 (12): 1473-1480.
  256. Machtay M, Rosenthal DI, Chalian AA, Lustig R, Hershock D, Miller L, Weber RS.. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. International Journal of Radiation Oncology Biology Physics 2004; 59 (1): 72-77.
  257. Macknelly A, Day J. A survey of techniques to reduce and manage external beam radiation-induced xerostomia in British oncology and radiotherapy departments. Radiography 2009; 15 (4): 283-291.
  258. Mah L, Orlowski C, Ververis K, Vasireddy RS, El-Osta A, Karagiannis TC. Evaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaks. Genome Integrity 2011; 2 (3): doi: 10.1186/2041-9414-2-3.
  259. Marcu LG. The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy. European Journal of Cancer Care 2009; 18 (2): 116-123.
  260. McCumber LM. The potential influence of cell protectors for dose escalation in cancer therapy: An analysis of amifostine. Medical Dosimetry 2004; 29 (2): 139-143.
  261. Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. International Journal of Radiation Oncology Biology Physics 2006; 66 (2): 445-453.
  262. Mell LK, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Mundt AJ. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: A meta-analysis. International Journal of Radiation Oncology Biology Physics 2007; 68 (1): 111-118.
  263. Mell LK, Movsas B. Pharmacologic normal tissue protection in clinical radiation oncology: Focus on amifostine. Expert Opinion on Drug Metabolism and Toxicology 2008; 4 (10): 1341-1350.
  264. Mendicote Léon F. Toxicity and support treatment in radiotherapeutic oncology. Toxicity in the field of O.R.L. prevention and treatment. [Toxicidad y tratamientos de soporte en oncología radioterápica. Toxicidad en el área de O.R.L. prevención y tratamiento] Oncologia2005; 28 (2): 30-34.
  265. Montero Luis A, Hervás A, Morera R, Ramos A. Skin and mucosal toxicity: Support treatments. [Toxicidad sobre piel y mucosas: Tratamientos de soporte] Oncologia 2004; 27 (7): 22-27.
  266. Montero A, Morera R, Hervás A, Sancho S, Ramos A. Mucositis during irradiation: Prevention and management. [Mucositis durante la irradiación: Prevención y manejo] Oncologia 2003; 26 (4): 39-45.
  267. Moss RW. Do antioxidants interfere with radiation therapy for cancer? Integrative Cancer Therapies 2007; 6 (3): 281-292.
  268. Münter MW, Hoffner S, Hof H, Herfarth KK, Haberkorn U, Rudat V, Karger CP. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: Comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without amifostine. International Journal of Radiation Oncology Biology Physics 2007; 67 (3): 651-659.
  269. Murdoch D. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: An evidence-based review. Current Opinion in Oncology 2007; 19 (3): 216-221.
  270. Nagy K, Urban E, Fazekas O, Thurzo L, Nagy E. Controlled study of lactoperoxidase gel on oral flora and saliva in irradiated patients with oral cancer. Journal of Craniofacial Surgery 2007; 18 (5): 1157-1164.
  271. Ng AK, Hickey G, Li S, Neuberg D, Mauch PM. A randomized phase II trial of amifostine for head and neck irradiation in lymphoma. Seminars in Oncology 2004; 31 (SUPPL. 18): 20-24.
  272. Nguyen NP, Levinson B, Dutta S, Karlsson U, Kelly KC, Dowell J, Sallah S. Amifostine and curative intent chemoradiation for compromised cancer patients. Anticancer Research 2003; 23 (2 C): 1649-1656.
  273. Norales G, Maria V, De Guzman A, Leonard R, Aref A. Amifostine-induced back pain: A case report. American Journal of Health-System Pharmacy 2006; 63 (4): 381-382.
  274. Okoturo EM, Trivedi NP, Kekatpure V, Gangoli A, Shetkar GS, Mohan M, Kuriakose MA. A retrospective evaluation of submandibular gland involvement in oral cavity cancers: A case for gland preservation. International Journal of Oral and Maxillofacial Surgery 2012; 41 (11): 1383-1386.
  275. Ozsahin M, Betz M, Matzinger O, Bron L, Luthi F, Pasche P, Zouhair A. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy. Archives of Otolaryngology - Head and Neck Surgery 2006; 132 (2): 141-145.
  276. Pamujula S, Graves RA, Kishore V, Mandal TK. Preparation and in vitro characterization of amifostine biodegradable microcapsules. European Journal of Pharmaceutics and Biopharmaceutics 2004; 57 (2): 213-218.
  277. Paunesku D, Paunesku T, Wahl A, Kataoka Y, Murley J, Grdina DJ, Woloschak GE. Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with amifostine. International Journal of Radiation Biology 2008; 84 (8): 623-634.
  278. Plataniotis GA, Dale RG. Radiobiologic modeling of cytoprotection effects in radiotherapy. International Journal of Radiation Oncology Biology Physics 2007; 68 (1): 236-242.
  279. Platteaux N, Dirix P, Dejaeger E, Nuyts S. Dysphagia in head and neck cancer patients treated with chemoradiotherapy. Dysphagia 2010; 25 (2): 139-152.
  280. Porter SR, Fedele S, Habbab KM. Taste dysfunction in head and neck malignancy. Oral Oncology 2010; 46 (6): 457-459.
  281. Porter SR, Fedele S, Habbab KM. Xerostomia in head and neck malignancy. Oral Oncology 2010; 46 (6): 460-463.
  282. Rades D, Fehlauer F, Bajrovic A, Mahlmann B, Richter E, Alberti W. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiotherapy and Oncology 2004; 70 (3): 261-264.
  283. Ren Z, Bai C, Jin Y, Zeng Z, Hong Q. Role of amifostine in the administration of concurrent radiation and chemotherapy with docetaxel. Fudan University Journal of Medical Sciences 2003; 30 (2): 167-169.
  284. Rodríguez-Caballero A, Torres-Lagares D, Robles-García M, Pachón-Ibáñez J, González-Padilla D, Gutiérrez-Pérez JL. Cancer treatment-induced oral mucositis: A critical review. International Journal of Oral and Maxillofacial Surgery 2012; 41 (2): 225-238.
  285. Rolim AEH, da Costa LJ, Ramalho LMP. Impact of radiotherapy on the orofacial region and management of related conditions. [Repercussões da radioterapia na região orofacial e seu tratamento] Radiologia Brasileira 2011; 44 (6): 388-395.
  286. Rosenthal DI. Established and emerging uses of cytoprotection in head and neck cancer. Archives of Otolaryngology - Head and Neck Surgery 2006; 132 (2): 129-130.
  287. Rosenthal DI, Blanco AI. Head and neck squamous cell carcinoma: Optimizing the therapeutic index. Expert Review of Anticancer Therapy 2005; 5 (3): 501-514.
  288. Rosenthal DI, Chambers MS, Weber RS, Eisbruch A. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Seminars in Oncology 2004; 31 (SUPPL. 18): 25-28.
  289. Rothstein JP. Radiation therapy and oral care. Dentistry Today 2005; 24 (3): 66-71.
  290. Saadeh CE. Chemotherapy- and radiotherapy-induced oral mucositis: Review of preventive strategies and treatment. Pharmacotherapy 2005; 25 (4): 540-554.
  291. Saavedra MM, Henríquez-Hernández LA, Lara PC, Pinar B, Rodríguez-Gallego C, and Lloret M. Amifostine modulate radio-induced apoptosis of peripheral blood lymphocytes in head and neck cancer patients. Journal of Radiation Research 2010; 51 (5): 603-607.
  292. Sagowski C, Tesche S, Zywietz F, Wenzel S, Metternich FU. The radioprotectors amifostine and sodium selenite do not modify the radiosensitivity of rat rhabdomyosarcomas. Onkologie 2004; 27 (1): 54-57.
  293. Samuels MA. Cytoprotection in head and neck cancer: Issues in oral care. Journal of Supportive Oncology 2004; 2 (6 SUPPL. 3): 9-12.
  294. Sasse AD, De Oliveira Clark LG, Sasse EC, Clark OACAmifostine reduces side effects and improves complete response rate during radiotherapy: Results of a meta-analysis. International Journal of Radiation Oncology Biology Physics 2006; 64 (3): 784-791.
  295. Scrimger R. Salivary gland sparing in the treatment of head and neck cancer. Expert Review of Anticancer Therapy 2011; 11 (9): 1437-1448.
  296. Seikaly H, Jha N, Harris JR, Barnaby P, Liu R, Williams D, Hanson J. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Archives of Otolaryngology - Head and Neck Surgery 2004; 130 (8): 956-961.
  297. Shaharyar Jave, AA, Shah IH, Ansari TN, Rasool S, Faheem M, Afridi MA. A phase II study of gemcitabine concurrent with radiation in locally advanced squamous cell carcinoma of head and neck: A trial of the cancer research group pakistan. Pakistan Journal of Medical Sciences 2006; 22 (3): 258-264.
  298. Shiboski CH, Hodgson TA, Ship JA, Schiødt M. Management of salivary hypofunction during and after radiotherapy. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2007; 103 (SUPPL.): S66.e1-S66.e19.
  299. Ship JA, Hu K. Radiotherapy-induced salivary dysfunction. Seminars in Oncology 2004; 31 (SUPPL. 18): 29-36.
  300. Silverma Jr S. Diagnosis and management of oral mucositis. Journal of Supportive Oncology 2007; 5 (2 SUPPL. 1): 13-21.
  301. Skinner WKJ, Muse ED, Yaparpalvi R, Guha C, Garg MK, Kalnicki S. Obtaining normal tissue constraints using intensity modulated radiotherapy (IMRT) in patients with oral cavity, oropharnygeal, and laryngeal carcinoma. Medical Dosimetry 2009; 34 (4): 279-284.
  302. Stiff PJ, Emmanouilides C, Bensinger WI, Gentile T, Blazar B, Shea TC, Spielberger R. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. Journal of Clinical Oncology 2006; 24 (33): 5186-5193.
  303. Stokman MA, Spijkervet FKL, Boezen HM, Schouten JP, Roodenburg JLN, De Vries EGE. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: Results of meta-analyses. Journal of Dental Research 2006; 85 (8): 690-700.
  304. Tamamura H, Ohoguchi M, Ichioka K, Ohta K, Higashi K, Tonami H. The efficacy of a steroid mixture for chemoradiotherapy-induced acute mucositis. Journal of JASTRO 2005; 17 (3): 169-175.
  305. Theis VS, Sripadam R, Ramani V, Lal S. Chronic radiation enteritis.Clinical Oncology 2010; 22 (1): 70-83.
  306. Thomas CT, Ammar A, Farrell JJ, Elsaleh H. Radiation modifiers: Treatment overview and future investigations. Hematology/oncology Clinics of North America 2006; 20(1): 119-139.
  307. Vélez I, Tamara LA, Mintz S. Management of oral mucositis induced by chemotherapy and radiotherapy: An update. Quintessence International 2004; 35 (2): 129-136.
  308. Veness MJ, Foroudi F, Gebski V, Timms I, Sathiyaseelan Y, Cakir B, Tiver KW. Use of topical misoprostol to reduce radiation-induced mucositis: Results of a randomized, double-blind, placebo-controlled trial. Australasian Radiology 2006; 50 (5): 468-474.
  309. Vissink A, Burlage FR, Spijkervet FKL, Jansma J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Critical Reviews in Oral Biology and Medicine 2003; 14 (3): 213-225.
  310. Wasserman TH, Brizel DM, Henke M, Monnier A, Eschwege F, Sauer R, Strnad V. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. International Journal of Radiation Oncology Biology Physics 2005; 63 (4): 985-990.
  311. Watanabe T, Ishihara M, Matsuura K, Mizuta K, Itoh Y. Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer. International Journal of Cancer 2010; 127 (8): 1984-1990.
  312. Winczura P, Jassem J. Combined treatment with cytoprotective agents and radiotherapy. Cancer Treatment Reviews 2010; 36 (3): 268-275.
  313. Wright JR, McKenzie M, DeAngelis C, Foroudi F, Paul N, Rajaraman M, Wong KSR. Radiation induced mucositis: Co-ordinating a research agenda. Clinical Oncology 2003; 15 (8): 473-477.
  314. Wu JC, Beale KK, Ma JD. Evaluation of current and upcoming therapies in oral mucositis prevention. Future Oncology 2010; 6 (11): 1751-1770.
  315. Xunclà M, Barquinero JF, Caballín MR, Craven-Bartle J, Ribas M, De Vega JM, Barrios L. Cytogenetic damage induced by radiotherapy. Evaluation of protection by amifostine and analysis of chromosome aberrations persistence. International Journal of Radiation Biology 2008; 84 (3): 243-251.
  316. Yun HJ, Bogaerts J, Awada A, Lacombe D. Clinical trial design limitations in head and neck squamous cell carcinomas.Current Opinion in Oncology 2007; 19 (3): 210-215.
  317. Büntzel J, Glatzel M, Mücke R, Micke O, Bruns F. Influence of amifostine on late radiation-toxicity in head and neck cancer-a follow-up study. Anticancer Research July-August 2007; 27 (4A): 1953-1956.
  318.  Blanco A, Chao C. Management of radiation-induced head and neck injury. Radiation Toxicity: A Practical Guide. Cancer Treatment and Research Volume 2006; 128: 23-41
  319. Garden AS, Chambers MS. Head and neck radiation and mucositis. Current Opinion in Supportive and Palliative Care 2007; 1 (1): 30-34.
  320. Lopes CO, Mas JRI,  Zângaro RA. Low level laser therapy in the prevention of radiotherapy-induced xerostomia and oral mucositis Radiologia Brasileira 2006; 39 (2): doi.org/10.1590/S0100-39842006000200012.
  321. Brizel DM. Strategies for protecting normal tissue in the treatment of head and neck cancer. Squamous Cell Head and Neck Cancer. Current Clinical Oncology 2005; 227-237.
  322. de la Vega FA, Domínguez MAD, Burgaleta AM, García RV, Echeverría Zabalza ME, Mundin EO,  Martínez López E, Rojano PR, Iture EV. Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinomas. Preliminary results of a phase II, single-institutional trial. Clinical and Translational Oncology 2005; 7 (2): 60-65.
  323. Salazar M, Victorino FR,  Paranhos LR, Ricci ID, Gaetti WP, Caçador NP.Efeitos e tratamento da radioterapia de cabeça e pescoço de interesse ao cirurgião dentista-Revisão da literatura. Odonto 2008; 16: (31). https://www.metodista.br/revistas/revistasims/index.php/O1/article/viewArticle/606.
  324. N Rotter, C Wirz, J Oder, B Wollenberg, R Huss, Brandau S,Cell-based strategies for salivary gland regeneration.
  325. Lang S, Bücheler M  HNO 2008, 56(3):281-287. ukpmc.ac.ukHNO
  326. Ramos A, Hervás A, Montero Á, Morera R. La oncología radioterápica moderna: situación actual- AlfredoRamos, AsunciónHervás, ÁngelMontero, RosaMorera, SonsolesSancho, SofíaCórdoba, JuanAntonioCorona, IsabelRodríguezInicio > Vol 1, No 1 (2004) > Ramos
  327. Ngeow WC, Chai WL, Zain RB. Management of radiation therapy-induced mucositis in head and neck cancer patients. Part I: clinical significance, pathophysiology and prevention. Oncology Reviews 2008; 2 (2): 102-113
  328. Dörr W, Riesenbeck D, Nieder C. Early and late treatment-induced toxicity. In  Brown JM, Mehta MP, Nieder C.(eds) Multimodal Concepts for Integration of Cytotoxic Drugs. Medical Radiology. Springer 2006, Ch 21, pp 317-332. ISBN 978-3-540-25655-7.
  329. Mao J, Fatunase OA, Marks LB. Cytoprotection for radiation-associated normal tissue injury. Radiation Oncology Advances. Cancer Treatment and Research. 2008; 139: 302-322
  330. Moss R. Do Antioxidants Reduce the Efficacy of Radiotherapy? In Arora R (eds) Herbal Radiomodulators: Applications in Medicine, Homeland Defence and Space. CAB International 2008, Ch 22.
  331. Bakke M, Bardow A, Møller E. Severe Drooling and Treatment With Botulinum Toxin. Perspectives on Swallowing and Swallowing Disorders (Dysphagia) ASHA 2012; 21: 15-21. doi:10.1044/sasd21.1.15
  332. Emmanouilides C. Palifermin (Kepivance™) in the treatment of mucositis. Hematology Meeting Reports. Published: 2009-05-29 16:12:46 DOI: 10.4081/hmr.v1i8.282
  333. Gérard JP. L’iatrogenèse médicale. Parfois le prix de la guérison. Revue de Stomatologie et de Chirurgie Maxillo-faciale, Elsevier 2004.
  334. Harris DJ, Eilers JG. What interventions are effective for managing oral mucositis in people receiving treatment for cancer? In Harris DJ, Eilers JG (eds). Putting Evidence into Practice: Improving Oncology Patient Outcome. Publisher: Oncology Nursing Society. 2009, pp. C201-C213. ISBN: 978-1-890504-84-7.
  335. Lundy D, Sullivan P. Xerostomia. Perspectives on Swallowing and Swallowing Disorders (Dysphagia). ASHA 2012; 21 (1): 22-27.
  336. Rasool S, Faheem M, Mehmood H, Shaharyar MA, Javed AA, Shah IH, Ansar TN, Khan MS, Afrid MA. A phase II study of gemcitabine concurrent with radiation in locally advanced squamous cell carcinoma of head and neck: A trial of the Cancer Research. Pakistan Journal of Medical Sciences 2006; 22 (3): 258-264.
  337. Sullivan CA. Etiology, Pathogenesis, and Treatment of Radiation-induced Xerostomia. In Witt RL (eds) Salivary Gland Diseases: Surgical and Medical Management. Springer 2006, Ch 14.
  338. Khuntia D, Traynor AM, Harari PM, Bourhis J. Applications in Head and Neck Cancer. In: Multimodal Concepts for Integration of Cytotoxic Drugs, Medical Radiology (eds). Springer 2006, Ch 13, pp 187-196.
  339. Begley A. The Effects of Comvita Manuka Honey on Oral Mucositis in Patients treated with Radiation Therapy to the Head and Neck. Thesis, University of Otago 2011. Retrieved from http://hdl.handle.net/10523/2021
  340. Junn JC, Sciubba JJ, Bishop JA, Zinreich E, Tang M, Levine MA, Palermo RA, Fakhry C, Blanco RG, Saunders JR, Califano JA, Ha PK. The Effect of Amifostine on Submandibular Gland Histology after Radiation. International Journal of Otolaryngology 2012; Article ID 508279.
  341. Nicolatou-Galitis O, Sarri T, Bowen J,  Di Palma M, Kouloulias VE, Niscola P,  Riesenbeck D,  Stokman M,  Tissing W, Yeoh E, Elad S, Lalla RV. Systematic review of amifostine for the management of oral mucositis in cancer patients. Supportive Care in Cancer 2013; 21 (1): 357-364
  342. Ruiz Alonso A. Irradiación radical convencional e hiperfraccionada del carcinoma de cabeza y cuello localmente avanzado : ensayos predictivos de toxicidad mediante estudios de radiosensibilidad de linfocitos in vitro y estudio de calidad de vida :tesis doctoral. Doctoral Thesis 2008. http://hdl.handle.net/10553/2256
  343. Junqueira J Jr. Efeito gastroprotetor da amifostina (ETHYOL®) na lesão gástrica induzida por etanol em ratos: papel dos grupos sulfidrílicos não-protéicos e neurônios sensoriais aferentes. Thesis 2008. http://hdl.handle.net/123456789/2420
  344. Benazzo M, Bertino G, Strada M. Sequele tardive da trattamento: prevenzione e cura. In Licitra L, Olmi P. (Eds.) Tumori della testa e del collo. Integrazione terapeutica nella conservazione della funzione d'organo. Springer 2011, Ch 17, pp 237-247.ISBN 978-88-470-1806-8.
  345. Rolim AEH, da Costa LJ, Pedreira Ramalho LM. Impact of radiotherapy on the orofacial region and management of related conditions. Radiologia Brasileira 2011; 44 (6) : 388-395.
  346. van Amerongen AN. Speekselklieraandoeningen en speeksel. In (eds) van Amerongen AN.Speeksel, speekselklieren en mondgezondheid, Springer 2009, Ch 16, pp 245-270. ISBN 978-90-313-6317-9.
  347. Bourhis J, Blanchard P, Maillard E, Brizel DM, Movsas B, Buentzel J. Effect of Amifostine on Survival Among Patients Treated With Radiotherapy: A Meta-Analysis of Individual Patient Data. Journal of Clinical Oncology 2011; 29 (18): 2590-2597.
  348. Mah LJ, Orlowski C, Ververis K, Vasireddy RS, El-Osta A, Karagiannis TC. Evaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaks. Genome Integrity 2011; 2:3 doi:10.1186/2041-9414-2-3.
  349. Prasad KN. Micronutrients in Health and Disease. CRP Press 2011, page 164.
  350. Balboni TA.Palliative care and symptom management in the head and neck cancer patient. In Heron  DE, Tishler RB. (eds) Head and Neck Cancer. DemosMedical 2011, pp 273-294.
  351. Choy H, Mac Rae R, Story M.Basic concepts of chemotherapy and irradiation interaction. In Halperin EC, Pérez CA, Brady LW. Perez and Brady's Principles and Practice of Radiation Oncology (eds), 5th edition. Lippincott Williams and Wilkins 2008, Ch 29,pp 669-688.
  352. Williamson JF, Brenner DJ. Psysics and biology of radiotherapy. In Halperin EC, Pérez CA, Brady LW. Perez and Brady's Principles and Practice of Radiation Oncology (eds), 5th edition. Lippincott Williams and Wilkins 2008, Ch 19, pp 423-475.
  353. Blanco AI, Chao C. Management of radiation-induced head and neck injury.In Small W, Woloschak GE. Radiation Toxicity: A Practical Medical Guide (eds). Springer 2006, Ch 2, pp 23-42.
  354. Stubblefield M, O'Del M. Cancer Rehabilitation: Principles and Practice (eds).2009 demosMedical.
  355. Kumar S, Ternel A, Clark GT.Treatment of oral mucositis and non-infectious, non-neoplastic oral ulcerations. In Clark GT, Dionne RA Orofacial Pain: A Guide to Medications and Management (eds). Wiley-Blackwell 2012, Ch 12, pp 184-211 (207).
  356. Carr E. Head and neck malignancies.In Yarbro CH, Goodman M, Frogge MH. Cancer Nursing: Principles and Practice (eds). Jones and Bartlett Publishers Inc. 2005, Ch 54, pp 1295-1329 (p 1328).
  357. Tan JKH. Developments in Healthcare Information Systems and Technologies: Models and methods (eds). IGI Global Snippet, 20102010 (page 313). ISBN 1616920033, 9781616920036.
  358. Figueiredo Ferreira PR.Tratamento Combinado em Oncologia: Quimioterapia, Hormonioterapia, Radioterapia(eds). 2007, page 128. ISBN 978-85-363-0929-3.
  359. American Cancer Society, National Center for Biotechnology Information (U.S.). Cancer 6 medicine (eds). 2003, Volume 6 - Page 1370. ISBN 1550092138, 9781550092134
  360. Eisele DW, Smith RV. Complications in head and neck surgery (eds). Saunders/Elsevier  2009, page 177. ISBN 1416042202, 9781416042204
  361. Picus J, Marin MG. Gastrointestinal complications of chemotherapy. In Perry MC. The Chemotherapy Source Book (eds), 4th ed. Lippincott Williams and Wilkins 2008, Ch 21, pp 197-208 (page 208).  
  362.  Mukherjee N, Carroll BL, Spees JL, Delay ER. Pre-treatment with amifostine protects against cyclophosphamide-induced disruption of taste in mice. PLoS APLosOne. 2013 Apr 23;8(4):e61607. doi: 10.1371/journal.pone.0061607.
  363.  Junn JC, Sciubba JJ, Bishop JA, Zinreich E, Tang M, Levine MA, Palermo RA, Fakhry C, Blanco RG, Saunders JR, Califano JA, Ha PK. The effect of amifostine on submandibular gland histology after radiation. International Journal of Otolaryngology. 2012;2012:508279. doi: 10.1155/2012/508279. Epub 2012 Jul 15.
  364.  Shadad AK, Sullivan FJ,Martin JD, Egan LJ. Gastrointestinal radiation injury: Prevention and treatment. World Journal of Gastroenterology 2013; 19(2): 199–208.
  365.  Cabrera AR, Yoo DS, Brizel DM. Contemporary Radiotherapy in Head and Neck Cancer: Balancing Chance for Cure with Risk for Complication. Surgical Oncology Clinics of North America 2013; 22(3): 579–598.
  366.  Sarhaddi D, Tchanque-Fossuo CN, Poushanchi B, Donneys A, Deshpande SS, Weiss DM, Buchman SR. Amifostine Protects Vascularity and Improves Union in a Model of Irradiated Mandibular Fracture Healing. Plastic and Reconstructive Surgery 2013; 132(6): 1542–1549. doi: 10.1097/PRS.0b013e3182a80766.
  367.  Stănilă A, SabăuD, Stef L, Sabău M. Pathological aspects of the oral mucosa caused by chemotherapy or radiotherapy in patients with cervical malignant adenopathies. Dry mouth and oral mucositis. Acta Medica Transilvanica 2013; 18(3): 333-334. 
  368.  Bowen J. Prevention of oral mucositis in head and neck cancer patients: A systematic review. Thesis (M.Phil.). University of Adelaide, The Joanna Briggs Institute, 2012. digital.library.adelaide.edu.au.
  369. Sandhu A, Ioffe V, Karakla D, Wadsworth JT, Mendoza A, Rao N, Dignan K, Mason E, Goffman TE. Prospective Single-Arm Study of Radioprotection by Amifostine in High Dose Radioactive Iodine Therapy for Thyroid Cancer. Journal of Postgraduate Medicine, Education and Research 2012; 46(2): 90-94.
  370.  Cabrera AR, Yoo DS,, Brizel DM. Contemporary Radiotherapy in Head and Neck Cancer. Balancing Chance for Cure with Risk for Complication  (Review). Surgical Oncology Clinics of North America 2013; 22(3): 579-598.
  371. Epstein JB, Thariat J, Bensadoun R-J, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E. Oral complications of cancer and cancer therapy: From cancer treatment to survivorship  (Review). CA Cancer Journal for Clinicians 2012; 62(6): 400-422.  
  372. Oral hygiene and periodontal treatment needs in young people with special needs attending a special school in Greece. Tsami A, Pepelassi E, Gizani S, Komboli M, Papagianoulis L, Mantzavinos Z. Journal of Disability and Oral Health 2004, 5: 57-64. (4 citations)
  373. Odugba FA, Akindayomi Y. Oral health status and treatment needs of children and young adults attending a day centre for individuals with special health care needs. BMC Oral Health 2008; 8: 30. doi:10.1186/1472-6831-8-30.
  374. Oredugba FA. Oral health condition and treatment needs of a group of Nigerian individuals with Down syndrome. Down Syndrome Research and Practice 2007; 12 (1): 72-76.
  375. Kakudate N, Morita M, Kawanami M. Oral health care-specific self-efficacy assessment predicts patient completion of periodontal treatment: A pilot cohort study. Journal of Periodontology 2008; 79: 1041-1047.
  376. Oredugba FA, Perlman SS. Oral health condition and treatment needs of Special Olympics athletes in Nigeria. Special Care in Dentistry 2010; 30(5): 211-217.
  377. Root caries in periodontally treated patients in relation to their compliance with suggested periodontal maintenance intervals. Pepelassi E, Tsami A, Komboli M. Compendium of Continuing Education in Dentistry 2005; 26(12): 835–44. (12 citations)
  378. Badiah B, Kang PL, Hor WS, Razali M, Dom TNM. Exploring factors influencing adherence to oral hygiene care among periodontal patients: A pilot study. Sains Malaysiana 2013; 42 (1): 13-17.
  379. Bizhang M, Chun Y-P, Heisrath D, Purucker P, Singh P, Kersten T, Zimmer S. Microbiota of exposed root surfaces after fluoride, chlorhexidine, and periodontal maintenance therapy: A 3-year evaluation.Journal of Periodontology2007; 78 (8): 1580-1589.
  380. Fadel H, Al Hamdan K, Rhbeini Y, Heijl L, Birkhed D. Root caries and risk profiles using the cariogram in different periodontal disease severity groups.Acta Odontologica Scandinavica2011; 69 (2): 118-124.
  381. Islas-Granillo H, Borges-Yañez SA, Medina-Solís CE, Casanova-Rosado AJ, Minaya-Sánchez M, Villalobos Rodelo JJ, Maupomé G. Socioeconomic, sociodemographic, and clinical variables associated with root caries in a group of persons age 60years and older in mexico.Geriatrics and Gerontology International 2012;12 (2): 271-276.
  382. Sánchez-García S, Reyes-Morales H, Juárez-Cedillo T, Espinel-Bermúdez C, Solõrzano-Santos F, García-Peña C. A prediction model for root caries in an elderly population.Community Dentistry and Oral Epidemiology 2011; 39 (1): 44-52. January 2006; 85: 89-93.
  383. Patrick R. Risiken und Nebenwirkungen der Parodontitis-Therapie Restaurative Möglichkeiten zur Verbesserung ästhetischer Defizite im  Fokus. Schmidlin Schweiz Monatsschr Zahnmed 2012; 122 (5): 427-431.
  384. Collins FM. Factoring patient compliance into oral care. Academy of Dental Therapeutics and Stomatology. www.ineedce.com, 2008: 16-26. www.ineedce.com/courses/2059/PDF/1103_CEDfpc-compliance.
  385. Balanoff WL. Periodontal maintenance in disease prevention. Publication date: January 2008, 2-11. www.ineedce.com/courses/2227/PDF/1102CEIT _Z_rpm_rev7.pd.
  386. Petersson LG, Hakestam U. Prevention av rotkaries med fluor och probiotika. Tandlakartidningen Arg 2009; 101 NR 3: 64-65.
  387. Liu X, He Y, Xue J, Chu J. Analysis of S.mutans in root surface plaque of periodontitis patients before and after treatment. Journal of Practical Stomatology 2009; 25: 1.
  388. Rudolph H, Luthardt RG. Gerontologie: Zahnmedizin nach Mab. ZWR 2006; 115: 368-380.
  389. Dental Economics, Dental Economics Division of Petroleum Publishing 2008; 98 (1-4), page iv.
  390. Gingival fibromatosis and significant tooth eruption delay in an 11-year-old male: A 30-month follow-up. Kavvadia K, Pepelassi E, Alexandridis C, Arkadopoulou A, Polyzois G, Tossios K. InternationalJournalofPaediatricDentistry2005; 15: 294-302.  (18 citations)
  391. Poulopoulos A, Kittas D. Current concepts on gingival fibromatosis‐related syndromes. Journal of Investigative and Clinical Dentistry 2011; 2 (3): 156–161.
  392. Reddy MS, Manyam R, Babu MN, Saraswathi TR. Gingival fibromatosis with hemi-osseous hyperplasia of jaws, focal maxillary viral papillomatosis of gingiva, fissured tongue and congenitally missing anterior teeth: a case report and surgical management of a new syndrome. Indian Journal of Dental Research 2011; 22 (3):489-92.
  393. Lai B, Muenzer J, Roberts MW. Idiopathic gingival hyperplasia: a case report with a 17-year followup. Case Rep Dent. 2011; 2011:986237. doi: 10.1155/2011/986237. Epub 2011 Jul 3.
  394. Livada R. Gummy Smile: Could It Be Genetic? Hereditary Gingival Fibromatosis. Journal of the Tennessee Dental Association 2011; 92-1: 23-26.
  395. Sato N, Ueno T, Kubo K, Suzuki T, Tsukimura N, Att W, Yamada M, Ogawa TN. Acetyl cysteine (NAC) inhibits proliferation, collagen gene transcription, and redox stress in rat palatal mucosal cells. Dental Materials 2009; 25 (12): 1532-1540.
  396. Martelli Jr H, Bonan PRF, Dos Santos LAN, Santos SMC, Cavalcanti MG, Coletta RD. Case reports of a new syndrome associating gingival fibromatosis and dental abnormalities in a consanguineous family. Journal of Periodontolog 2008; 79 (7): 1287-1296.
  397. Brooks JK, Bare LC, Davidson J, Taylor LS, Wright JT. Junctional epidermolysis bullosa associated with hypoplastic enamel and pervasive failure of tooth eruption: Oral rehabilitation with use of an overdenture. OralSurgery, OralMedicine, OralPathology, OralRadiologyandEndodontology 2008; 105(4): e24-e28.
  398. Korbmacher HM, Lemke R, Kahl-Nieke B. Progressive preeruptive crown resorption in autosomal recessive generalized hypoplastic Amelogenesis Imperfecta. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2007; 104 (4): 540-544.
  399. Coletta RD, Graner E. Hereditary gingival fibromatosis: A systematic review. Journal of Periodontology 2006; 77(5): 753-764.
  400. Lai B, Muenzer J, Roberts MW. Idiopathic Gingival Hyperplasia: A Case Report with a 17-Year Follow up. Hindawi Publishing Corporation Case Reports in Dentistry 2011; doi:10.1155/2011/986237.
  401. Millet C, Rodier P, Farges JC, Labert N, Duprez JP. Surgical and prosthetic treatment in an elderly patient affected by unilateral idiopathic gingival fibromatosis: a case report. Gerodontology 2012; 29(2): e1185-e1189.
  402. Sanjay B, Shushant KG, Sanjeev M, Sangeeta G.  Esthetic Reconstruction of Partially Edentulous Maxilla with Traumatic Gingival Hyperplasia: A Clinical Report. Journal of Clinical Case Reports 2012; 2: 125. doi:10.4172/2165-7920.1000125
  403. Boka V, Markopoulos AK., Poulopoulos AK. Tooth eruption: Topical and systemic factors that influence the process. Balkan Journal of Stomatology 2009; (13) 1: 11-14.
  404. Poulopoulos A, Kittas D, Sarigelou A. Current concepts on gingival fibromatosis-related syndromes. Journal of Investigative and Clinical Dentistry 2011; 2(3): 156 - 161. DOI:10.1111/j.2041-1626.2011.00054.x
  405. Ceccarelli-Calle JF, Ricaldi-Camahualí J, Berastain-Arenas JF. Fibromatosis gingival. Diagnóstico y tratamiento: Reporte de un caso. Revista Estomatologica Herediana. 2010; 20(3): 161-165.
  406. Jankowski J, Janas A, Grzesiak-Janas G. Gingival fibromatosis. In Kim SI, Suh TS.World Congress of Medical Physics and Biomedical Engineering. Imaging the future Medicine. August 27- September 1, 2006. COEX Seoul, Korea (eds). Springer 2007, volume 14/1, pp.1317-1319 (page 1319). ISBN 1680-0737.
  407. He L, Ping FY.Gingival fibromatosis with multiple unusual findings: report of a rare case.International Journal of Oral Science 2013; 4(4):221.
  408. Raja TA, Albadri S, Hood S.Rutherfurd syndrome associated with Marfan syndrome.European Archives of Paediatric Dentistry 2008;9(3): 138. 
  409.  Time-and dose-dependent mitogenic effect of bFGF combined with different bone graft materials. An in vitro study. Dereka XE, Markopoulou CE, Mamalis A, Pepelassi E, Vrotsos IA. ClinicalOralImplantsResearch 2006; 17(5): 554-559. (10 citations)
  410. Akman AC, Tiǧli RS, Gumusderelioglu M, Nohutcu RM. bFGF-loaded HA-chitosan: A promising scaffold for periodontal tissue engineering. Journal of Biomedical Materials Research - Part A 2010; 92 (3): 953-962.
  411. Cartmell S. Controlled release scaffolds for bone tissue engineering.Journal of Pharmaceutical Sciences2009; 98 (2): 430-441.
  412. Dereka XE, Markopoulou CE, Mamalis A, Vrotsos IA. Effect of rhBMP-7 combined with two bone grafts on human periodontal ligament cell differentiation.Growth Factors 2009; 27 (5): 274-279.
  413. Kaur P, Puneet, Dahiya V. Platelet-rich plasma: A novel bioengineering concept. Trends in Biomaterials and Artificial Organs 2011; 25 (2): 86-90.
  414. Li Y, Lee I-S, Cui F-Z, Choi S-H. The biocompatibility of nanostructured calcium phosphate coated on micro-arc oxidized titanium.Biomaterials2008; 29 (13): 2025-2032.
  415. Li Y, Lee I -S, Cui F-Z, Lin Z, Park J-C, Chung S-M. Incorporation of cytochrome C with thin calcium phosphate film formed by electron-beam evaporation.Surface and Coatings Technology 2008; 202 (22-23): 5742-5745.
  416. Pantou AL, Markopoulou CE, Dereka XE, Vavouraki H, Mamalis A, Vrotsos IA. The effect of platelet-rich plasma (PRP) combined with a bone allograft on human periodontal ligament (PDL) cells.Cell and Tissue Banking 2012; 13 (1): 81-88.
  417. Tiemann AH Schmidt HGK, Braunschweig R, Hofmann GO. Strategies for the analysis of osteitic bone defects at the diaphysis of long bones. Strategies in Trauma and Limb Reconstruction 2009; 4 (1): 13-18.
  418. Bacakova L, Filova E, Parizek M, Ruml T, Svorcik V. Modulation of cell adhesion, proliferation and differentiation on materials designed for body implants. Biotechnology Advances 2011; 29 (6):739-767.
  419. Gu Z, Kong L, Feng X, Guo T, Dai J, Li S, Huo N, Ding Y. Synthesis and characterization of PLGA–gelatin complex with growth factor incorporation as potential matrix. Journal of Alloys and Compounds 2009; 474(1-2): 450-454.
  420. Platelet-rich plasma effect on periodontally affected human gingival fibroblasts: an in vitro study. Pepelassi E, Markopoulou C, Dereka X, Mamalis A, Vrotsos I. Journal of the International Academy of Periodontology 2009;11(1): 160-168. (2 citations)
  421. Wolbank S, van Griensven M, Grillari-Voglauer R, Peterbauer-Scherb A. Alternative sources of adult stem cells: Human amniotic membrane. Advances in Biochemical Engineering/Biotechnology2010; 123: 1-27.
  422. Wolbank S, van Griensven M, Grillari-Voglauer R, Peterbauer-Scherb A. Alternative sources of adult stem cells: human amniotic membrane. In Kasper C, van Griensven M, Pörtner R. Bioreactor Systems for Tissue Engineering II: Strategies for the expansion and directed differentiation of stem cells (eds). Springer 2010, volume 2, pp 1-28 (page 26).
  423. Effect of homologous PRP on proliferation of human periodontally affected osteoblasts. In vitro preliminary study. Report of a case. Markopoulou CE, Markopoulos P, Dereka XE, Pepelassi E, Vrotsos IA. Journal of  Musculoskeletal Neuronal Interactions 2009; 9(3): 167-172. (8 citations)
  424. Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. (). Platelet-rich plasma: A milieu of bioactive factors. Arthroscopy - Journal of Arthroscopic and Related Surgery 2012; 28 (3): 429-439.
  425. Huang S, Wang Z. Influence of platelet-rich plasma on proliferation and osteogenic differentiation of skeletal muscle satellite cells: An in vitro study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2010; 110 (4): 453-462.
  426. Jo CH, Kim JE, Yoon KS, Shin S. Platelet-rich plasma stimulates cell proliferation and enhances matrix gene expression and synthesis in tenocytes from human rotator cuff tendons with degenerative tears. American Journal of Sports Medicine 2012; 40 (5): 1035-1045.
  427. Mazzocca AD, McCarthy MBR, Chowaniec DM, Dugdale EM, Hansen D, Cote MP,  Bradley JP, Romeo AA, Arciero RA, Beitzel K. The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. American Journal of Sports Medicine 2012; 40(8): 1742-1749. doi: 10.1177/ 0363546512 452713.
  428. Pantou AL, Markopoulou CE, Dereka XE, Vavouraki H, Mamalis A, Vrotsos IA. The effect of platelet-rich plasma (PRP) combined with a bone allograft on human periodontal ligament (PDL) cells. Cell and Tissue Banking 2012; 13 (1): 81-88.
  429. Jo CH, Kim JE, Yoon KS, Shin S. Platelet-Rich Plasma Stimulates Cell Proliferation and Enhances Matrix Gene Expression and Synthesis in Tenocytes From Human Rotator Cuff Tendons With Degenerative Tears. The American Journal of Sports Medicine 2012; 40 (5): 1035-1045.
  430.  Amrichová J, Špaková T, Rosocha J, Harvanová D, Bačenková D, Lacko M, Horňák S. Effect of PRP and PPP on proliferation and migration of human chondrocytes and synoviocytes in vitro. Central European Journal of Biology 2014; 9(2): 139-148.
  431. Boswell SG, Schnabel LV, Mohammed HO, Sundman EA, Minas T, Fortier LA. Increasing Platelet Concentrations in Leukocyte-Reduced Platelet-Rich Plasma Decrease Collagen Gene Synthesis in Tendons. Am J Sports Med January 2014; 42 (1): 42-49.   
  432. Parameters affecting tooth loss during periodontal maintenance in a Greek population. Tsami A, Pepelassi E, Kodovazenitis G, Komboli M. Journal of the American Dental Association 2009; 140(9): 1100-1107. (8 citations)
  433. Bäumer A, Pretzl B, Cosgarea R, Kim T, Reitmeir P, Eickholz P, Dannewitz B. Tooth loss in aggressive periodontitis after active periodontal therapy: Patient-related and tooth-related prognostic factors. Journal of Clinical Periodontology 2011; 38(7): 644-651.
  434. Chambrone L, Chambrone D, Lima LA, Chambrone LA. Predictors of tooth loss during long-term periodontal maintenance: A systematic review of observational studies. Journal of Clinical Periodontology 2010; 37 (7): 675-684.
  435. Godard A, Dufour T, Jeanne S. Application of self-regulation theory and motivational interview for improving oral hygiene: A randomized controlled trial. Journal of Clinical Periodontology 2011; 38 (12): 1099-1105.
  436. Jung SH, Ryu JI, Jung DB. Association of total tooth loss with socio-behavioural health indicators in Korean elderly. Journal of Oral Rehabilitation 2011; 38 (7): 517-524.
  437. Miyamoto T, Kumagai T, Lang MS, Nunn ME. Compliance as a prognostic indicator. II. Impact of patient's compliance to the individual tooth survival. Journal of Periodontology 2010; 81 (9): 1280-1288.
  438. Schmidt E, Kaciroti N, Loesche W. Benefits of additional courses of systemic azithromycin in periodontal therapy.General Dentistry 2011; 59 (3): 180-187.
  439. Nibali L, Farias BC, Vajgel A, Tu YK, Donos N. Tooth Loss in Aggressive Periodontitis: A Systematic Review. Journal of Dental Research 2013 92: 868. DOI: 10.1177/0022034513501878
  440. Costa, F.O., Oliveira, A.M.S.D., Cortelli, J.R., Cota, L.O.M., Oliveira, P.A.D. Recurrence, progression of periodontitis and tooth loss associated with surgical or non-surgical procedures in periodontal maintenance therapy: An overview. (Chapter  ). In  Current Trends in Periodontics and Implant Dentistry (eds) (Anand, V., Gulati, M). Nova Science Publishers, Inc.2013. ISBN: 978-162618819-8.  
  441. Treatment of periodontal endosseous defects with platelet-rich plasma alone or in combination with demineralized freeze-dried bone allograft: A comparative clinical trial. Markou N, Pepelassi E, Vavouraki H, Stamatakis HC, Nikolopoulos G, Vrotsos I, Tsiklakis K.Journal of Periodontology 2009; 80(12): 1911-1919. (17 citations)
  442. Andrade MGS, Moreira DC, Dantas DB, Sa CN, De Bittencourt TCBDSC, Sadigursky M. Pattern of osteogenesis during onlay bone graft healing. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2010; 110 (6): 713-719.
  443. Del Corso, M, Vervelle A, Simonpieri A, Jimbo R, Inchingolo F, Sammartino G, Dohan Ehrenfest DM. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: Periodontal and dentoalveolar surgery. Current Pharmaceutical Biotechnology 2012; 13 (7): 1207-1230.
  444. Del Fabbro M, Bortolin M, Taschieri S, Weinstein R. Is platelet concentrate advantageous for the surgical treatment of periodontal diseases? A systematic review and meta-analysis. Journal of Periodontology 2011; 82 (8): 1100-1111.
  445. Dong Z, Li B, Liu B, Bai S, Li G, Ding A, Zha J, Liu Y. Platelet-rich plasma promotes angiogenesis of prefabricated vascularized bone graft. Journal of Oral and Maxillofacial Surgery 2012; 70 (9): 2191-2197.
  446. Dumitrescu AL. Chemicals in Surgical Periodontal Therapy (eds). Springer 2011, page 298.
  447. Goyal B, Tewari S, Duhan J, Sehgal PK. Comparative evaluation of platelet-rich plasma and guided tissue regeneration membrane in the healing of apicomarginal defects: A clinical study. Journal of Endodontics 2011; 37 (6): 773-780.
  448. Leventis MD, Eleftheriadis E, Oikonomopoulou P, Vavouraki H, Khaldi L, Tosios KI, Vardas E; Valavanis K, Dontas I. Experimental study of the effect of autologous platelet-rich plasma on the early phases of osteoinduction by allogenic demineralized bone matrix.Implant Dentistry2012; 21 (5): 399-405.
  449. Pantou AL, Markopoulou CE, Dereka XE, Vavouraki H, Mamalis A, Vrotsos IA. The effect of platelet-rich plasma (PRP) combined with a bone allograft on human periodontal ligament (PDL) cells. Cell and Tissue Banking 2012; 13 (1): 81-88.
  450. Pradeep AR, Rao NS, Agarwal E, Bajaj P, Kumari M, Naik SB. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of 3-wall intrabony defects in chronic periodontitis: A randomized controlled clinical trial. Journal of Periodontology 2012; 83 (12): 1499-1507.
  451. Rodrigues SV, Acharya AB, Thakur SL. An evaluation of platelet-rich plasma without thrombin activation with or without anorganic bone mineral in the treatment of human periodontal intrabony defects.Platelets2011; 22 (5): 353-360.
  452. Schuckert K, Osadnik M. Bone tissue engineering in oral surgery: A new method of bone development in periodontal surgery.Tissue Engineering - Part C: Methods 2011; 17 (12): 1179-1187.
  453. Riggenbach MD, Jones GL, Bishop JY. Open reduction and internal fixation of clavicular nonunions with allograft bone substitute. InternationalJournal ofShoulderSurgery2011; 5(3): 61-67.doi: 10.4103/0973-6042.86232.
  454. Joseph VR, Raghunath A, Sharma N.Clinical effectiveness of autologous platelet rich fibrin in the management of infrabony periodontal defects. Singapore Dental Journal, 2012; 33 (1): 5-12.
  455. Roffi A, Filardo G, Kon E, Marcacci M Does PRP enhance bone integration with grafts, graft substitutes, or implants? A systematic review. BioMedCentral Musculosceletal Disorders 2013 Nov 21;14:330. doi: 10.1186/1471-2474-14-330.
  456. Miron RJ, Bosshardt DD, Laugisch O, Dard M, Gemperli AC, Buser D, Gruber R, Sculean A. In Vitro Evaluation of Demineralized Freeze-Dried Bone Allograft in Combination With Enamel Matrix Derivative. Journal of Periodontology 2013;84(11): 1646-1654.
  457. Hsu YT, Wang HL. How to Select Replacement Grafts for Various Periodontal and Implant Indications. Clinical Advances in Periodontics 2013; 3(3): 167-179
  458. Dong Z, Li B, Liu B, Bai S, Li G, Ding A, Zhao J, Liu Y. Platelet-rich plasma promotes angiogenesis of prefabricated vascularized bone graft. Journal of Oral and Maxillofacial Surgery 2012; 70(9): 2191-2197.
  459. The adjunctive use of platelet-rich plasma in the therapy of periodontal intraosseous defects: A systematic review. Kotsovilis S, Markou N, Pepelassi E, Nikolidakis D. Journal of Periodontal Research 2010; 45: 428–443. (27 citations)
  460. Alvarez P, Hee CK, Solchaga L, Snel L, Kestler HK, Lynch SE, Hollinger JO. Growth factors and craniofacial surgery. Journal of Craniofacial Surgery2012; 23 (1): 20-29.
  461. Creeper F, Ivanovski S. Effect of autologous and allogenic platelet-rich plasma on human gingival fibroblast function.Oral Diseases2012; 18 (5): 494-500.
  462. Del Corso M, Vervelle A, Simonpieri A, Jimbo R, Inchingolo F, Sammartino G, Dohan Ehrenfest DM. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: Periodontal and dentoalveolar surgery. Current Pharmaceutical Biotechnology 2012; 13 (7); 1207-1230.
  463. Del Fabbro M, Bortolin M, Taschieri S. Is autologous platelet concentrate beneficial for post-extraction socket healing? A systematic review. International Journal of Oral and Maxillofacial Surgery2011; 40 (9): 891-900.
  464. Del Fabbro M, Bortolin M, Taschieri S, Weinstein R. Is platelet concentrate advantageous for the surgical treatment of periodontal diseases? A systematic review and meta-analysis. Journal of Periodontology 2011; 82 (8): 1100-1111.
  465. Del Fabbro M, Ceresoli V, Lolato A, Taschieri S. Effect of platelet concentrate on quality of life after periradicular surgery: A randomized clinical study.Journal of Endodontics2012; 38 (6): 733-739.
  466. Fu JH, Wang HL. Platelet-rich plasma has no additional benefit during guided tissue regeneration procedure to significantly improve clinical attachment gains in the treatment of periodontal intrabony defects. Journal of Evidence-Based Dental Practice2012; 12 (1): 5-7.
  467. Herrera BS, Coimbra LS, Bastos AS, Teixeira SA, Steffens JP, Muscara MN, Spolidorio LC. Platelet-rich plasma stimulates cytokine expression and alkaline phosphatase activity in osteoblast-derived osteosarcoma cells.Archives of Oral Biology2012; 57 (9): 1282-1289.
  468. Pradeep AR, Rao NS, Agarwal E, Bajaj P, Kumari M, Naik SB. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of 3-wall intrabony defects in chronic periodontitis: A randomized controlled clinical trial.Journal of Periodontology 2012; 83 (12): 1499-1507.
  469. Reynolds MA, Aichelmann-Reidy ME. Protein and peptide-based therapeutics in periodontal regeneration. Journal of Evidence-Based Dental Practice 2012; 12 (3SUPPL.): 118-126.
  470. Yang M, Wang J, Wang Q. Promotional effects of autogeneic platelet-rich plasma on in vitro and in vivo osteoblastic ability of adipose-derived mesenchymal stem cells. Journal of Clinical Rehabilitative Tissue Engineering Research 2011; 15 (40): 7485-7488.
  471. Guruprasad CN, Pradeep AR, Agarwal E. Use of Platelet-Rich Plasma Combined With Hydroxyapatite in the Management of a Periodontal Endosseous Defect Associated With a Palato-Radicular Groove: A Case Report. Clinical Advances in Periodontics 2012; 2 (1): 28-33.
  472. Elangovan S, Avila-Ortiz G, Johnson GK, Karimbux N, Allareddy V. Quality Assessment of Systematic Reviews on Periodontal Regeneration in Humans. Journal of Periodontology 2012; (1) : doi: 10.1902/jop.2012.120021.
  473. Davis VL, Abukabda AB, Radio NM, Witt-Enderby PA, Clafshenkel WP, Cairone JV, Rutkowski JL. Platelet-Rich Preparations to Improve Healing. Part II: Platelet Activation and Enrichment, Leukocyte Inclusion, and Other Selection Criteria. Journal of Oral Implantology 2012 In-Press doi:http://dx.doi.org/10.1563/AAID-JOI-D-12-00106.1
  474. Raccomandazioni SIMTI sugli emocomponenti per uso non trasfusionale. Società Italiana di Medicina Trasfusionale 2012.www.simti.it/pdf/raccomandazioni_ emocomponenti_ testo_on.
  475. Aprili G, Gandini G, Guaschino R, Mazzucco L, Salvaneschi L, Vaglio S, SIMTI Working Group. SIMTI recommendations on blood components for non-transfusional use. Blood Transfusion 2013 Oct;11(4):611-622. doi: 10.2450/2013.0118-13. Epub 2013 Oct 3.
  476. Forni F, Marzagalli M, Tesei P, Grassi A. Platelet gel: applications in dental regenerative surgery. Blood Transfusion 2013 Jan;11(1):102-107. doi: 10.2450/2012.0007-12. Epub 2012 Jul 4.
  477. Schliephake, H. Clinical Efficacy of Growth Factors to Enhance Tissue Repair in Oral and Maxillofacial Reconstruction: A Systematic Review. Clinical Implant Dentistry and Related Research 2014; 16(1). doi: 10.1111/cid.12114
  478. Creeper F, Ivanovski S. Effect of autologous and allogenic platelet-rich plasma on human gingival fibroblast function. Oral Diseases 2014; 20(2). doi: 10.1111/j.1601-0825.2012.01897.x
  479. Zheng C, Zhu Q, Liu X, Huang X, He C, Jiang L, Quan D, Zhou X, Zhu Z. Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. Journal of Tissue Engineering and Regenerative Medicine 2014; 8(2). doi: 10.1002/term.1756
  480. Cetinkaya BO, Gonca Cayir Keles GC, Pamuk F, Balli U, Keles ZP. Long-term clinical results on the use of platelet concentrate in the treatment of intrabony periodontal defects.  Acta Odontologica Scandinavica 2014; 72(2): 92-98. doi:10.3109/00016357.2013.775668
  481. Gümüş P, Nizam N, Lappin DF, Buduneli N. Saliva and Serum Levels of B-Cell Activating Factors and Tumor Necrosis Factor-α in Patients With Periodontitis, Journal of Periodontology 2014; 85(2): 270-280. DOI 10.1902/jop.2013.130117
  482. Del Fabbro M, Ceci C, Taschieri C. Revisione sistematica della letteratura sull'effetto dei concentrati piastrinici nel trattamento chirurgico dei difetti parodontali.  Dental Cadmos 2013; 81(7): 393.
  483.  Larjava H, YangY, Putnins E, Heino J, Häkkinen L. Biological agents and cell therapies in periodontal regeneration. Endodontic Topics 2012; 26: 18–40. doi: 10.1111/etp.12020
  484. Del Fabbro M, Ceresoli V, Lolato A, Taschieri S. Effect of Platelet Concentrate on Quality of Life after Periradicular Surgery: A Randomized Clinical Study. Journal of Endodontics 2012;  38(6): 733. doi:10.1016/j.joen.2012.02.022
  485. Larjava H, Yang Y, Putnins E, Heino J, Häkkinen L. Biological Agents and Cell Therapies in Periodontal Regeneration, in Oral Wound Healing (ed H. Larjava), John Wiley & Sons, Ltd., West Sussex UK 2012, ch 11.  doi: 10.1002/9781118704509.ch11
  486. Petrović V, Pejčić N, Čakić S. The influence of different therapeutic modalities and platelet rich plasma on apexogenesis - A preliminary study in monkeys. Advances in Clinical and Experimental Medicine 2013; 22(4):469-479.Volume 22, Issue 4, July, Pages 469-479.
  487. The use of platelet-rich plasma combined with demineralized freeze-dried bone allograft in the treatment of periodontal endosseous defects: A report of two clinical cases. Markou N, Pepelassi E, Kotsovilis S, Vrotsos I, Vavouraki H, Stamatakis HC. Journal of the Americal Dental Association 2010; 141(8): 967- 978. (4 citations)
  488. Yang M, Wang J, Wang Q. Promotional effects of autogeneic platelet-rich plasma on in vitro and in vivo osteoblastic ability of adipose-derived mesenchymal stem cells. Journal of Clinical Rehabilitative Tissue Engineering Research 2011; 15 (40): 7485-7488.
  489. Moghaddas H, Kadkhodazadeh M, Pezeshkfar A. Comparison of the Palatal Connective Tissue Graft as a Membrane with Collagen Membrane in Combination with Bio-Oss and PRGF for Treatment of Intrabony Defects: A Randomized Clinical Trial. Journal Dental School 2012; 1: 30-40. Dumitrescu AL. Chemicals in Surgical Periodontal Therapy (eds). Springer 2011, page 298
  490. Bernabé PFE, Gomes-Filho JE, Dezan-Júnior E, Prieto AKC, Samuel RO, Cintra LTA. Combined therapy with mineral trioxide aggregate, and guided tissue regeneration for a large radicular cyst: A 13-year follow-up. Brazilian Journal of Oral Sciences 2013; 12(1): 66-70.
  491. Zhang X-A, Wu S-J, Lu H-B, Shi X-Q, Wang H-L, Cao Y-L, Li Y-X. Autologous platelet rich plasma repair facial nerve injury. Chinese Journal of Tissue Engineering Research 2013; 17(28): 5145-5150  DOI: 10.3969/j.issn.2095-4344.2013.28.008
  492. Clinical effectiveness of a desensitizing system on dentin hypersensitivity in periodontitis patients. Patsouri A, Mavrogiannea A, Pepelassi E, Gaintantzopoulou M, Kakaboura A. AmericalJournal ofDentistry2011; 24(2): 85-92.  (3 citations)
  493. McMahon AD, Blair Y, McCall DR, Macpherson LM. Reductions in dental decay in 3-year old children in Greater Glasgow and Clyde: repeated population inspection studies over four years. BMCOralHealth2011; 28: 11:29.doi: 10.1186/1472-6831-11-29.
  494. Farmakis E-R, Kozyrakis K, Khabbaz MG, Schoop U, Beer F, Moritz A. In vitro evaluation of dentin tubule occlusion by denshield and neodymium-doped yttrium-aluminum-garnet laser irradiation.Journal of Endodontics 2012; 38 (5): 662-666.
  495. Veitz-Keenan A, Barna JA, Stroller B, Matthews AG, Collie D, Vena D, Curro FA, Thompson VP. Treatments for hypersensitive noncarious cervical lesions: A Practitioners Engaged in Applied Research and Learning (PEARL) Network randomized clinical effectiveness study. Journal of the American Dental Association 2013;144(5): 495-506.
  496. The effect of smoking on the mRNA expression of MMPs and TIMP-1 in untreated chronic periodontitis patients: A cross-sectional study. Mouzakiti E, Pepelassi E, Fanourakis G, Markopoulou C, Tseleni-Balafouta S, Vrotsos I. Journal of Periodontal Research 2011; 46 (5): 576-583. (2 citations)
  497. Botero JE, Yepes FL, Roldán N, Castrillón CA, Hincapie JP, Ochoa SP, Ospina CA, Becerra MA, Jaramillo A, Gutierrez SJ, Contreras A. Tooth and periodontal clinical attachment loss are associated with hyperglycemia in patients with diabetes. Journal of Periodontology 2012;83 (10): 1245-1250.
  498. Mahendra L, Austin RD, Kumar SS, Mahendra JA,Felix AJW. Relationship between Psychological Stress, Serum Cortisol, Expression of MMP-1 and Chronic Periodontitis in Male Police Personnel. International Journal of Scientific & Engineering Research 2012; 3 (9): ISSN 2229-5518.
  499. Effect of rhTGF-β1 combined with bone grafts on human periodontal cell differentiation. Markopoulou CE, Dereka XE, Vavouraki HN, Pepelassi EA, Mamalis AA, Karoussis IK, Vrotsos IA. Growth Factors 2011; 29(1):14-20. (2 citations)
  500. Sood S, Gupta S, Mahendra A. Gene therapy with growth factors for periodontal tissue engineering-A review. Medicina Oral, Patologia Oral y Cirugia Bucal 2012; 17 (2): e301-e310.
  501. Maeda H, Wada N, Tomokiyo A, Monnouchi S, Akamine A. Prospective potency of TGF-β1 on maintenance and regeneration of periodontal tissue. International Review of Cell and Molecular Biology 2013; 304: 283-367.
  502. Dental and periodontal complications of lip and tongue piercing: Prevalence and influencing factors. Plessas A, Pepelassi E. Australian Dental Journal 2012; 57: 71–78. (5 citations)
  503. Giuca MR, Pasini M, Nastasio S, D'Ercole S, Tripodi D. Dental and periodontal complications of labial and tongue piercing. Journal of Biological Regulators and Homeostatic Agents 2012; 26(3): 553-560.
  504. Junping Y, Wei L, Keya S. Study of Ce-modified antibacterial 316L stainless steel. China Foundry, Research & Development 2012; 9 (4): 308-312.
  505. Bertl K, Durstberger G, Ulm C.Von der Planung bis zur Deckung gingivaler Rezessionen. Stomatologie 2013; 110(1-2): 21-26. DOI 10.1007/s00715-012-0196-7.
  506.  Kjellström A. Spatial and Temporal Trends in New Cases of Men with Modified Teeth from Sweden (ad 750–1100). European Journal of Archaeology 2014; 17(1):45-59.
  507.  Yuan J, Li W, Shen K. Study of Ce-modified antibacterial 316L stainless steel. China Foundry  2012; 9(4): 307-312.
  508.  The relationship between osteoporosis and periodontitis in women aged 45–70 years. Pepelassi E, Nicopoulou-Karayianni K, Archontopoulou AD, Mitsea A, Kavadella A, Tsiklakis K, Vrotsos I, Devlin H, Horner K. OralDiseases 2012; 18(4): 353–359. (8 citations)
  509. Wang Y, Sugita N, Yoshihara A, Iwasaki M, Miyazaki H, Nakamura K, H Yoshie H. Peroxisome proliferator-activated receptor (PPAR) γ polymorphism, vitamin D, bone mineral density and periodontitis in postmenopausal women. Oral Diseases 2013; 19 in press. doi:10.1111/odi.12032
  510. Bertulucci, LAB; Pereira, FMBG; Oliveira, AEF; Brito, LMO; Lopes, FF. Periodontal disease in women in post-menopause and its relationship with osteoporosis. Revista Brasileira de Ginecologia e Obstetrícia 2012; 34(12):563-3677.
  511. Singh A,Sharma RK, Siwach RC, Tewari S, Narula SC.Association of bone mineral density with periodontal status in postmenopausal women. Journal of Investigative and Clinical Dentistry 2014; 5(1). doi: 10.1111/jicd.12047
  512.  López-López J, Castellanos-Cosano L, Estrugo-Devesa A, Gómez-Vaquero C, Velasco-Ortega E, Segura-Egea JJ.Radiolucent periapical lesions and bone mineral density in post-menopausal women. Gerodontology 2014; 31. DOI: 10.1111/ger.12076
  513. Stein SH, Livada R, Tipton DA.Re-evaluating the role of vitamin D in the periodontium. Journal of Periodontal Research 2014;49(1): DOI: 10.1111/jre.12149
  514. Iwasaki M, Taylor GW, Nakamura K, Yoshihara A, Miyazaki H.Association Between Low Bone Mineral Density and Clinical Attachment Loss in Japanese Postmenopausal Females. Journal of Periodontology 2013;84 (12):1708.
  515. Xing W, Liu J, Cheng S, Vogel P, Mohan S, Brommage R.Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosi.Journal of Bone and Mineral Research 2013;28(9): 1962–1974.
  516.  Shintaku WH, Enciso R, Covington JS., Migliorati CA. Can dental students be taught to use dental radiographs for osteoporosis screening? Journal of Dental Education 2013; 77(5): 598-603.
  517. Expression of MMPs and TIMP-1 in smoker and nonsmoker chronic periodontitis patients before and after periodontal treatment. Mouzakiti E, Pepelassi E, Fanourakis G, Markopoulou C, Tseleni-Balafouta S, Vrotsos I. Journal of Periodontal Research 2012; 47 (4): 532-542. (2 citations)
  518. Yakob M, Meurman JH, Sorsa T, Söder B. Treponema denticola associates with increased levels of MMP-8 and MMP-9 in gingival crevicular fluid. OralDiseases2013; 19(7): 694-701. DOI: 10.1111/odi.12057
  519. Pawar DD, Mehta DS. Effect of phase 1 periodontal therapy on gingival crevicular fluid levels of matrix metalloproteinases-3 and -13 in chronic periodontitis patients. Journal of Investigative and Clinical Dentistry 2014; (5): 1. DOI: 10.1111/jicd.12072  
  520. Incidence of Bacteriocins Produced by Food-Related Lactic Acid Bacteria Active towards Oral Pathogens. Zoumpopoulou G, Pepelassi E, Papaioannou W, Georgalaki M, Maragkoudakis PA, Tarantilis PA, Polissiou M, Tsakalidou E, Papadimitriou K. International Journal of Molecular Sciences 2013, 14, 4640-4654; doi:10.3390/ijms14034640 (1 citation)
  521. Yi H, Han X, Yang Y, Liu W, Liu H, Zhang Y, Sun K, Zhang L, Ma F. Effect of exogenous factors on bacteriocin production from Lactobacillus paracasei J23 by using a resting cell system. International Journal of Molecular Sciences 2013;14(12):24355-24365.  
  522. Pepelassi E., Xynogala I., Perrea D., Agrogiannis G., Pantopoulou A., Patsouris E., Vrotsos I. Histometric Assessment of the Effect of Diabetes Mellitus on Experimentally Induced Periodontitis in Rats. Journal of the International Academy of Periodontology 2012; 14(2): 35-41. (2 citations)
  523. Cintra LTA, Samuel RO, Facundo ACS, Prieto AKC, Sumida DH, Bomfim SRM, Souza JC, Dezan-Júnior E, Gomes-Filho JE. Relationships between oral infections and blood glucose concentrations or HbA1c levels in normal and diabetic rats. International Endodontic Journal, 47, 228–237, 2014.
  524. Zhang J, Jiang L, Wang J, Zhou Q, Gao Y. Three-dimensional structure and morphology of the mandible in type 1 diabetes mellitus mice Chinese Journal of Tissue Engineering Research 2013 ;17 (28) : 5101-5107.    DOI: 10.3969/j.issn.2095-4344.2013.28.001
  525.  Xynogala I., Pepelassi E., Perrea D., Agrogiannis G., Pantopoulou A., Patsouris E., Vrotsos I. Adiponectin and interleukin-6 levels in insulin-treated diabetic rats with experimental periodontitis. Brazilian Oral Research 2012; 26(1): 71–76.  (1 citation)
  526. Chee B, Park B, Bartold M. Periodontitis and type II diabetes: a two-way relationship. International Journal of Evidence-Based Healthcare 2013; 11(4): 317-329.  
  527. Mouzakiti E., Pepelassi E., Fanourakis G., Markopoulou C., Tseleni-Balafouta S., Vrotsos I. The effect of smoking on the mRNA expression of MMPs and TIMP-1 in untreated chronic periodontitis patients: A cross-sectional study. Journal of Periodontal Research 2011; 46 (5): 576-583. (1 citation)
  528. Bondy-Carey JL, Galicia J, Bagaitkar J, Potempa JS, Potempa B, Kinane DF, Veillard F, Scott, DA. Neutrophils alter epithelial response to Porphyromonas gingivalis in a gingival crevice model. Molecular Oral Microbiology 2013; 28 (2): 102-113.

 

Eudoxie Pepelassi

Associate Professor

 

 

  • : (+30) 210-746-1223
    • DEPARTMENTDepartment of Periodontology, School of Dentistry
      National and Kapodistrian
      University of Athens
    • COUNTRYGreece